[go: nahoru, domu]

US20210307902A1 - Prosthetic Heart Valve Having an Improved Tubular Seal - Google Patents

Prosthetic Heart Valve Having an Improved Tubular Seal Download PDF

Info

Publication number
US20210307902A1
US20210307902A1 US17/351,868 US202117351868A US2021307902A1 US 20210307902 A1 US20210307902 A1 US 20210307902A1 US 202117351868 A US202117351868 A US 202117351868A US 2021307902 A1 US2021307902 A1 US 2021307902A1
Authority
US
United States
Prior art keywords
cases
tubular seal
end region
inches
fabric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/351,868
Inventor
Andrew J.H. Backus
Loren M. Crow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US17/351,868 priority Critical patent/US20210307902A1/en
Publication of US20210307902A1 publication Critical patent/US20210307902A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2439Expansion controlled by filaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0057Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0037Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0069Sealing means

Definitions

  • This document provides prosthetic heart valves having an improved tubular seal.
  • the human heart contains four valves: a tricuspid valve, a pulmonic valve, a mitral valve and an aortic valve.
  • the main purpose of the valves is to maintain unimpeded forward flow of blood through the heart and the major blood vessels connected to the heart, for example, the pulmonary artery and the aorta.
  • any one of the four heart valves may malfunction and result in either stenosis (impeded forward flow) and/or backward flow (regurgitation). Either process burdens the heart and may lead to serious problems, for example, heart failure.
  • Various procedures for fixing or replacing defective heart valves are known in the art.
  • artificial heart valves can be implanted in the heart of a patient to replace a diseased or damaged heart valve with a prosthetic equivalent to minimize stenosis and regurgitation.
  • Prosthetic heart valves can have a variety of designs. Two major types of prosthetic heart valves include mechanical heart valves and bioprosthetic heart valves.
  • Mechanical heart valves can be made of synthetic materials, such as plastics or metals, while bioprosthetic heart valves can be made of biologic tissue mounted on a fabric covered plastic or metal frame.
  • Bioprosthetic heart valves can include animal tissue, such as porcine or bovine tissue, that has been chemically treated to make the valve suitable for implantation in a human. Bioprosthetic valves do not generally require a patient to undergo anticoagulant therapy, which is typically required when using mechanical valves. But bioprosthetic valves can be more prone to device wear such as tears in the valve tissue that may require the valve to be replaced. There is therefore a need to further improve the design of bioprosthetic valves to retain its functionality during the life of the patient.
  • Prosthetic heart valves provided herein can have a structure adapted to retain functionality during the life of the patient and to minimize stenosis and regurgitation by having an improved connection between different parts of the prosthetic heart valve.
  • a tubular seal in Example 1, includes an outflow end region and an inflow end region.
  • the inflow end region can include a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.
  • Example 2 the tubular seal of Example 1, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
  • Example 3 the tubular seal of Example 1 or Example 2, wherein the woven fabric includes non-elastic fibers.
  • Example 4 the tubular seal of Example 1-3, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
  • Example 5 the tubular seal of Example 4, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
  • Example 6 the tubular seal of Example 4, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
  • Example 7 the tubular seal of one of Examples 1-6, wherein the interface of the woven fabric has a scalloped shape.
  • Example 8 the tubular seal of Example 7, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
  • Example 9 the tubular seal of Example 7, wherein the interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
  • Example 10 the tubular seal of Example 7, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
  • a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix.
  • the woven fabric can include a non-linear edge within the elastomeric polymer matrix.
  • Example 12 the tubular seal of one of Example 11, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
  • Example 13 the tubular seal of one of Examples 11 or 12, wherein the non-elastic fibers include a polyester.
  • Example 14 the tubular seal of one of Examples 11-13, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
  • Example 15 the tubular seal of one of Examples 11-14, wherein the inflow end region includes a first substantially uniform thickness and an outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • a prosthetic heart valve includes an expandable tubular member, a plurality of leaflets and a tubular seal.
  • the plurality of leaflets can be secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member.
  • the tubular seal can include a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member.
  • the tubular seal can include an outflow end region and an inflow end region.
  • the inflow end region can be a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
  • Example 17 the prosthetic heart valve of Example 16, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
  • Example 18 the prosthetic heart valve of Example 16, wherein the woven fabric includes the non-elastic fibers.
  • Example 19 the prosthetic heart valve of Example 18, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
  • Example 20 the prosthetic heart valve of Example 19, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
  • Example 21 the prosthetic heart valve of Example 19, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
  • Example 22 the prosthetic heart valve of Example 16, wherein the woven fabric includes non-elastic fibers arranged in the polymeric web to allow the tubular seal to stretch in axial and radial directions.
  • Example 23 the prosthetic heart valve of Example 16, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
  • Example 24 the prosthetic heart valve of Example 16, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • Example 25 the prosthetic heart valve of Example 16, wherein the outflow end region includes a plurality of grommets.
  • a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric that includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix.
  • the woven fabric includes a non-linear edge within the elastomeric polymer matrix.
  • Example 27 the tubular seal of Example 26, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape defining an interface between the inflow end region and the outflow end region.
  • Example 28 the tubular seal of Example 27, wherein the interface has a major radius R a that ranges from about 0.050 inches to about 0.100 inches.
  • Example 29 the tubular seal of Example 27, wherein interface has a minor radius R i that ranges from about from about 0.020 inches to about 0.040 inches.
  • Example 30 the tubular seal of Example 27, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
  • Example 31 the tubular seal of Example 26, wherein the non-elastic fibers include a polyester.
  • Example 32 the tubular seal of Example 26, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
  • Example 33 the tubular seal of Example 26, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • Example 34 the tubular seal of Example 26, wherein a thickness for the inflow end region ranges from about 0.0016 inches to about 0.0023 inches, or from about 40 microns to about 60 microns.
  • a method in Example 35, includes forming at least a portion of a tubular seal that includes a woven fabric within a matrix by dipping a mandrel with a first coating composition that includes at least one elastomeric polymer.
  • the method can also include drying the first coating composition and positioning the woven fabric on the mandrel such that fibers within the fabric are oriented at an angle of about 45 degrees with respect to a central axis of the tubular seal.
  • the method can further include applying a second coating composition on the mandrel, the second coating composition being different than the first coating composition and removing the tubular seal from the mandrel.
  • Prosthetic heart valves provided herein can additionally have a reduced unexpanded profile.
  • prosthetic heart valves provided herein include a plurality of anchor elements.
  • anchor elements can be secured to an expandable tubular member.
  • the expandable tubular member can be a braided stent.
  • prosthetic heart valves provided herein include three or more leaflets.
  • the leaflets can have a body portion and sleeve portions one or both sides. In some cases, sides of the body portions can be secured together and sleeve portions secured to anchor elements (e.g., anchor elements attached to a braided stent).
  • prosthetic heart valves provided herein can include a tubular seal.
  • the tubular seal can be secured to bottom edges of body portions of the leaflets.
  • the seal can be secured to a blood inlet side of an expandable member.
  • tubular seals provided herein can be applied to a variety of prosthetic heart valves provided herein (and within the scope of the claims), additional details about the overall structure of an exemplary prosthetic heart valve are provided below.
  • FIGS. 1A-1I illustrate an exemplary prosthetic heart valve and an exemplary deployment device provided herein.
  • FIGS. 1A and 1B are perspective views of the heart valve provided herein connected to the deployment device.
  • FIG. 1C is a side view of the exemplary prosthetic heart valve.
  • FIGS. 1D-1I illustrate how the exemplary heart valve provided herein can be delivered by the deployment device.
  • FIGS. 2A-2C illustrates an exemplary leaflet, which can be used in prosthetic heart valves provided herein.
  • FIG. 2A illustrates a rounded notch in a leaflet where a leaflet can be secured to an adjacent leaflet.
  • FIGS. 2B and 2C illustrate a side portion of the exemplary leaflet.
  • FIG. 2B depicts the rounded notch in an armpit of the exemplary leaflet.
  • FIG. 2C depicts attachment elements in the armpit of the exemplary leaflet.
  • FIG. 3 illustrates another exemplary leaflet, which can be used in prosthetic heart valves provided herein.
  • FIG. 3 depicts apertures in a body of the exemplary leaflet.
  • FIGS. 4A-4G illustrate how adjacent leaflets can be stitched together in prosthetic heart valves provided herein.
  • FIGS. 5A-5C illustrate a cross stich provided herein for connecting a seal to a braided stent in an exemplary prosthetic heart valve provided herein.
  • FIG. 5A shows a front view of a seal having apertures and stitch patterns used for securing the seal to the braided stent.
  • FIG. 5B depicts a close up view of a cross stitch and a portion of a circumferential stitch used for securing the seal to the braided stent.
  • FIG. 5C depicts a cross-sectional view showing the cross stitch and a portion of the circumferential stitch.
  • FIG. 6 depicts an apparatus that can be used to form a tubular seal provided herein.
  • FIGS. 7A-7G illustrate exemplary tubular seals that include a fabric having a non-linear edge positioned within a polymeric web or matrix in a prosthetic heart valve provided herein.
  • FIGS. 8A-8C illustrate an exemplary tubular seal having a scalloped, non-linear edge in a prosthetic heart valve provided herein.
  • FIGS. 1A and 1B illustrate an exemplary prosthetic heart valve 100 provided herein.
  • FIGS. 1A and 1B are perspective views of prosthetic heart valve 100 connected to a deployment device 190 .
  • FIG. 1C is a side view of prosthetic heart valve 100 .
  • prosthetic heart valve 100 includes an expandable member 110 , three leaflets 200 , three anchor elements 120 that secure sleeve portions 216 of leaflets 200 to expandable member 110 , and a tubular seal 130 secured around a blood inflow end of prosthetic heart valve 100 .
  • FIG. 1A does not show components that are located underneath tubular seal 130 , but FIG.
  • Anchor elements 120 can include post leg compression elements 122 and clamping support structures 126 adapted to provide support along opposite sides of the sleeve portions 216 . Expandable member 110 in
  • FIGS. 1A-1I is a braided stent (which can also be described as a braided anchor element), which is adapted to transition between a restricted state having a smaller diameter and an expanded state having a larger diameter.
  • Expandable member 110 can be self-expanding, mechanically expanded, or a combination thereof
  • FIGS. 1D-1I depict how an exemplary heart valve delivery system 180 can deliver and deploy prosthetic heart valve 100 provided herein within a blood vessel.
  • System 180 can include a sheath 182 for retaining prosthetic heart valve 100 with the expandable member 110 in a restricted state.
  • Tubular seals provided herein can have a uniform thickness or a thickness that has a non-linear interface between an inflow end region and an outflow end region to provide a transition zone between a thinner outflow end region to the thicker inflow end region that facilitates loading of prosthetic heart valve 100 into sheath 182 .
  • a substantially uniform thickness or a transition zone can reduce the probability for sections of the tubular seal to catch on an outer rim of sheath 182 during loading of prosthetic heart valve 100 in a restricted state.
  • tubular seals provided herein can allow for radial and/or axial expansion of the tubular seal in portions including non-elastic fibers, accordingly, a tubular seal used in prosthetic heart valves provided herein can have a non-expanded diameter that expands to the predetermined outer diameter of the expandable member and that stretches to an axially elongated but radially restricted configuration when prosthetic heart valve 100 is in a restricted state to further reduce the profile of prosthetic heart valve 100 within sheath 182 .
  • anchor elements 120 FIGS. 1A-1C
  • a pull line 194 can be connected to a nose cap 196 , or end cap, which is positioned at the end of sheath 182 .
  • the pull line 194 can extend through expandable member 110 and through the valve opening between the leaflets 200 .
  • FIGS. 1D-1I once a distal end of sheath 182 is delivered through the circulatory system to an appropriate location (e.g., within the heart), prosthetic heart valve 100 can be deployed.
  • prosthetic heart valve 100 can be pushed out of sheath 182 .
  • expandable member 110 can self-expand upon exiting sheath 182 .
  • expandable member 110 can self-expand to a first intermediate diameter
  • system 180 can mechanically expand expandable member 110 to a larger deployment diameter.
  • anchor elements 120 can include a locking mechanism to clip a portion of expandable member when the expandable member 110 is expanded to a predetermined locking diameter.
  • system 180 can mechanically expand expandable member 110 to a predetermined locking diameter.
  • system 180 can compress expandable member 110 between pushing prongs 192 and nose cap 196 by moving pull line 194 relative to pushing prongs 192 .
  • the predetermined locking diameter can be adapted to set the diameter of prosthetic heart valve 100 during implantation. After prosthetic heart valve 100 is set, system 180 can move pull line 194 and nose cap 196 relative to pushing prongs 192 to move the end cap through the opening between leaflets 200 in prosthetic heart valve 100 . Pushing prongs 192 can then be retracted from anchor elements 120 and retracted into sheath 182 .
  • pushing prongs 192 can include a shape member material adapted to help radially expand expandable member 110 as the expandable member 110 exits sheath 182 .
  • a control handle 188 can be used to control the relative movements of sheath 182 , pushing prongs 192 , and pull wire 194 .
  • Prosthetic heart valves provided herein can be adapted to mitigate damage that may occur to valves during delivery and implantation.
  • one or more radiopaque markers can be secured to prosthetic heart valves provided herein.
  • expandable member 110 includes a radiopaque marker 112 .
  • Any suitable radiopaque material such as platinum, palladium, gold, tantalum, or alloys thereof
  • One or more radiopaque markers can be used with an imaging system to help a physician ensure that a valve is set in an appropriate location.
  • prosthetic heart valves provided herein include at least three radiopaque markers.
  • prosthetic heart valve 100 can include a plurality of leaflets 200 .
  • prosthetic heart valve 100 includes three leaflets 200 .
  • prosthetic heart valves provided herein can have any suitable number of leaflets, such as two, three, four, five, or more leaflets.
  • leaflets 200 are secured to one another.
  • leaflets 200 can be secured to one another by a suture (not shown) or a plurality of sutures.
  • Leaflets 200 can be sutured alongside edges of a body portion of each leaflet.
  • prosthetic heart valves provided herein can include a single line of sutures, which can be adapted to minimize leaks, minimize the width of a seam, and/or minimize the profile of a replacement heart valve during a percutaneous insertion. In some cases, prosthetic heart valves provided herein can include multiple lines of sutures.
  • Expandable member 110 can have any suitable structure, arrangement, or material.
  • expandable member 110 can include a braided wire stent.
  • a braided wire stent For example, U.S. Publication Number 2005/0143809, titled, “Methods and Apparatus for Endovascularly Replacing a Heart Valve,” and filed on Nov. 5, 2004, which is herein incorporated by reference for its disclosure of possible structures and materials for a braided wire stent, discloses a braided wire stent.
  • expandable member 110 includes a shape memory material (e.g., a nickel-titanium alloy or a cobalt-chromium alloy).
  • FIGS. 2A-2C provide illustrations of an exemplary leaflet 200 that includes a body portion 214 and sleeve portions 216 .
  • body portion 214 has a bottom edge 222 , a first side edge 226 , a second side edge 228 , and a free edge 224 .
  • Leaflet 200 further includes a front (i.e., a side facing the blood inflow end of a prosthetic heart valve), a back (i.e., a side facing the blood outflow end), a first side adjacent to the first side edge 226 , and a second side adjacent to the second side edge 228 .
  • the front of leaflet 200 has a different texture than the back.
  • the back or front can have a non-textured or textured surface to mitigate calcium buildup on the surfaces.
  • the back of leaflet 200 may be prone to calcium build due to a cusp-shaped, concave surface, thus it can be beneficial to have a textured surface on the back of leaflet 200 to mitigate calcification issues.
  • Leaflets can be made of various synthetic or non-synthetic materials.
  • the leaflet 200 is made from tissue obtained from an animal, e.g., a pig or a cow.
  • leaflet 200 is made from bovine pericardium.
  • leaflets 200 can be made from a synthetic polymers or composites.
  • Leaflets 200 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 200 and stitching the leaflets 200 together along stitch line 246 , which is shown in FIG. 2C .
  • leaflet 200 defines at least one notch 232 , 234 between at least one of the two side edges 226 , 228 and a corresponding adjacent sleeve portion 216 .
  • Each notch 232 , 234 can be located along side edges 228 , 226 at a location adjacent to the sleeve portions 216 , e.g., at an “armpit” of leaflet 200 as depicted in FIGS. 2A and 2B .
  • leaflet 200 can define a notch along the length of side edges 228 , 226 .
  • a notch can be defined along sleeve portion 216 .
  • multiple notches can be located along sleeve portion 216 , side edges 228 , 226 , and/or at the armpit of the leaflet 200 .
  • body portion 214 of leaflet 200 has a conical frustum shape defined by bottom edge 222 , first side edge 226 , second side edge 228 , and free edge 224 .
  • Other suitable shapes for the body portion can include, but are not limited to, for example, a generally square, rectangular, triangular or trapezoidal shaped body portion.
  • the sleeve portions 216 can extend outwardly from the body portion 214 of the leaflet 200 .
  • Each sleeve portion 216 can oriented at an angle relative to a portion of the body portion, e.g., free edge 224 of body portion 214 .
  • Sleeve portions 214 as shown, can be generally rectangular-shaped extensions with lateral free ends. In some cases, sleeve portions 214 can have rounded free ends.
  • notches 232 , 234 can be generally U-shaped. Other suitable notch shapes can include, but are not limited to, a V-shaped, rectangular-shaped, oval-shaped, and circular notch. In some cases, notches 232 , 234 can have rounded edges to smooth the transition between a notch 232 , 234 and side edges 228 , 226 of leaflet 200 . Notches 232 , 234 can have a length dimension that can range from about 0.5 millimeters (mm) to about 4 mm (from about 0.02 inches to about 0.20 inches).
  • notches 232 , 234 can be shaped and sized to accommodate attachment of post leg compression elements 122 .
  • Post leg compression elements 122 can be a part of anchor elements 120 (shown in FIGS. 1A-1C ) that compress and restrain sleeve portions 216 along the same line as the stitch line 246 .
  • suture 258 can be used to apply an appropriate and consistent compressive force between post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of leaflets 200 . Since suture 258 pass through notches 232 , 234 , it does not need to pass through body portion 214 at or near the armpit of leaflet 200 .
  • a notched leaflet 200 can improve valve opening capabilities and the reliability of prosthetic heart valves provided herein.
  • FIG. 3 illustrates another exemplary leaflet 300 , which can be used in prosthetic heart valves provided herein.
  • leaflet 300 can include a body portion 314 and at least two opposite sleeve portions 316 .
  • the body portion 314 can be defined by at least two side edges 326 , 328 adjacent each sleeve portion 316 .
  • Leaflet 300 can define two apertures 332 and 334 .
  • Each aperture 332 , 334 can be positioned adjacent side edges 326 , 328 and the corresponding adjacent sleeve portion 316 .
  • body portion 314 has a bottom edge 322 , a first side edge 326 , a second side edge 328 , and a free edge 324 .
  • Leaflet 300 further includes a front, a back, a first side adjacent to the first side edge 326 , and a second side adjacent to the second side edge 328 .
  • Leaflets 300 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 300 and stitching the leaflets 300 together along stitch line 246 , as shown in FIG. 2C .
  • leaflet 300 defines apertures 332 and 334 adjacent side edges 328 , 326 and adjacent one of the sleeve portions 316 .
  • Apertures 332 and 334 can be generally circular in shape. Other suitable aperture shapes can include, but are not limited to, for example, a rectangular, oval, triangular, or diamond-shaped aperture.
  • apertures 332 , 334 can have a length dimension or a diameter from about 0.5 mm to about 4 mm (or about 0.02 inches to about 0.20 inches).
  • one or more apertures 332 , 334 can be located in the side edges 328 , 326 and/or the sleeve portions 316 of the leaflet 300 . In some cases, multiple apertures can be located in a region that is adjacent to the side edges 328 , 326 and the sleeve portions 316 .
  • Apertures 332 , 334 in the leaflets 300 can allow one leaflet to be secured to an adjacent leaflet. Similar to the notches discussed above, apertures 332 and 334 can be shaped and sized to accommodate attachment of post leg compression elements 122 .
  • post leg compression elements 122 can be a part of anchor elements 120 that compress and restrain sleeve portions 216 along the same line as the stitch line 246 .
  • a suture 258 can be used to apply an appropriate and consistent compressive force between the post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of the leaflets 200 .
  • sutures that pierce the body portion 214 at or near the armpit of the leaflet can create stress concentrations at or near the armpit of the leaflet that may result in tearing.
  • Apertures 332 and 334 and post leg compression elements 122 can minimize this potential tearing caused by sutures near the armpit location by being positioned proximate to the post leg compression elements near the armpit.
  • Apertures 332 , 334 create enlarged openings that allow suture 258 to pass therethrough without pulling or stretching adjacent tissue areas. Accordingly, leaflets 300 used in prosthetic heart valves provided herein can improve the reliability of prosthetic heart valves.
  • FIGS. 4A-4G depict how leaflets 200 can be connected (or jointed) with an improved stitch discussed herein.
  • stitch 446 can be a single continuous line stitch traveling along a stitch line in a forward direction and back in a reverse direction.
  • stitch 446 can run along a leaflet from a bottom edge to a side edge of the leaflet (e.g., bottom edge 222 to side edge 226 of leaflet 200 in FIG. 2A-2B ).
  • stitch 446 can run from a side edge to a notch of a leaflet (e.g., side edge 226 to notch 234 of leaflet 200 in FIG. 2A-2B ).
  • stitch 446 can include a plurality of perpendicular loop segments 434 extending through an aperture in the two leaflets, around outer side edges of the two attached leaflets, and back through the aperture.
  • Stitch 446 can include a plurality of parallel segments 436 extending between adjacent apertures along the stitch line.
  • Stitch 446 can include two perpendicular loop segments 434 extending through apertures formed in the stitch line. In some cases, a first perpendicular loop segment 434 for a first aperture in the stitch line is formed when the stitch is formed in the forward direction and a second perpendicular loop segment 434 for the first aperture is formed in the reverse direction.
  • parallel segments 436 made in a forward direction alternate between opposite sides of the two leaflets between each aperture in the stitch line.
  • parallel segments 436 made in a reverse direction are formed on an opposite side of the two leaflets from parallel segments 436 made in a forward direction.
  • opposite parallel segments 436 made in the forward and reverse directions can provide a continuous compressive force along the entire length of the stitch line.
  • Perpendicular loop segments 434 can provide compressive force to reinforce a seal formed between the two leaflets along the stitch line.
  • Stitch 446 can include any appropriate number of perpendicular loop segments formed through any appropriate number of apertures. As shown, stitch 446 includes six perpendicular loop segments formed through six apertures (two perpendicular loop segments per aperture). In some cases, stitch 446 can include up to twelve perpendicular loop segments formed through six or more apertures. In some cases, a stitch connecting side edge segments of leaflets can be formed using between 3 and 20 apertures and include between 3 and 40 perpendicular loop segments. In some cases, apertures can be positioned from about 0.2 mm to about 10 mm apart (or about 0.008 inches to about 0.4 inches apart). In some cases, apertures can be positioned from about 0.2 mm to about 10 mm (or about 0.008 inches to about 0.4 inches) away from the side edges of the leaflets.
  • Stitch 446 can be formed in a process depicted in FIGS. 4A-4G .
  • a thread needle 410 can be passed through aligned leaflet side edges 226 a and 226 b to create a first aperture at a location near bottom edges 222 , e.g., a location approximately 1 mm from the bottom edges 222 .
  • the leaflet side edges 226 a and 226 b can be retained in a desired configuration by clamping the leaflets between clamp sides 422 and 424 . Needle 410 pulls a leading end 431 of a thread 432 through the first aperture. As shown in FIG.
  • needle 410 can then form a second aperture adjacent to the first aperture along the stitch line (towards the leaflet sleeve portion) about 0.5 mm away from the first aperture to pull leading end 431 of thread 432 through the second aperture to form a first parallel segment.
  • a perpendicular loop segment 434 can be made by guiding needle 410 around the leaflet side edges and re-enter the second aperture from a backside. Thread 432 can be pulled through the second aperture until it sits firmly against the leaflet material (e.g., leaflet pericardium tissue).
  • FIG. 4D shows a second parallel segment, which can be made by pushing needle 410 through leaflet tissue along the stitch line to form a third aperture approximately 1 mm from the second aperture (towards the sleeve segments of the leaflet).
  • a second perpendicular loop segment 434 can be formed by again having needle 410 loop around the leaflet side edges and reenter the third aperture through the backside. This is repeated up to notch 234 to form a total of six parallel segments 436 and six perpendicular loop segments 434 in a forward direction, as shown in FIG. 4F .
  • the stitch pattern can then be repeated in a reverse direction towards the bottom edges 222 of the leaflets through the previously formed apertures.
  • each aperture can include two perpendicular loop segments 434 and parallel segments on the opposite sides can be formed from the parallel segments that were created in the forward direction, as shown in FIG. 4G .
  • the method and stitches depicted in FIGS. 4A-4G can be applicable to leaflets 200 , 300 discussed herein.
  • Stitch 446 and other stitches provided herein can improve the reliability of a seal formed along a stitch line, create fewer apertures through the leaflets, and simplify the stitching operation. Having fewer apertures can help minimize the occurrence of blood leakage through the apertures.
  • the single continuous line of stitch 446 using a single row of apertures can minimize a width of a side edge portion needed to form a continuous seal along the side edges of the leaflets, thus providing a reduced restricted profile for prosthetic heart valves provided herein.
  • U.S. Pat. No. 8,778,020 describes a variety of ways that leaflets can be sutured together using combinations of whip stitches and running stitches, but these stitches require additional apertures and multiple lines.
  • Perpendicular loop segments 434 can stitch a plurality of leaflets together, similar to the whip stitches discussed in U.S. Pat. No. 8,778,020.
  • Parallel segments 436 can secure valve leaflets to one another, similar to the running stitches discussed in U.S. Pat. No. 8,778,020.
  • stitch 446 can provide an improved attachment between side edges of leaflets in prosthetic heart valves provided herein, some embodiments of prosthetic heart valves provided herein can use other stitch patterns, such as those described in U.S. Pat. No. 8,778,020, which is hereby incorporated by reference.
  • Important characteristics of a suture thread can include, but are not limited to, adequate tensile strength, abrasion resistance and creep rupture resistance characteristics that allow the device to be delivered into and sustain implantation within a human anatomy.
  • the thread used for suturing together portions of the heart valve, e.g., side edges of the leaflets can be composed of biocompatible materials that include, but are not limited to, polyethylene such as ultra high molecular weight polyethylene (UHMWPE), polyester (PET), and a combination thereof.
  • UHMWPE ultra high molecular weight polyethylene
  • PET polyester
  • tubular seal 130 of prosthetic heart valve 100 can be secured to bottom edges 222 ( FIG. 2A ) of body portion 214 of leaflet 200 by a circumferential running stitch 134 .
  • tubular seal 130 can be secured to expandable member 110 by fasteners, such as grommets 136 , and extended around the outside of expandable member 110 to provide a seal that minimizes blood leakage around the leaflets 200 of an implanted prosthetic heart valve 100 .
  • fasteners such as grommets 136
  • FIGS. 5A-5C provide an improved tubular seal stitching pattern can include a cross stitch 132 between tubular seal 130 and expandable member 110 .
  • a blood inlet side of expandable member 110 e.g., braided anchor element
  • FIGS. 5A-5C illustrate how the tubular seal 130 can be secured to the expandable member 110 , e.g., a braided stent, by a plurality of cross stitches connecting the tubular seal 130 to a pair of overlapping wire members of the braided stent.
  • expandable member 110 can be a braided stent including one or more wires having a first set of segments 114 extending helically in a first direction and a second set of segments 116 extending helically in a second direction such that the first set of segments 114 cross the second set of segments 116 at intersection points 118 .
  • one or more wires can have inflow crowns 115 at an end of the braided stent where the wires transition from first segments 114 to second segments 116 .
  • cross stitches 132 secure tubular seal 130 at an intersection 118 to two crossing segments 114 , 116 of the braided stent.
  • a separate circumferential running stitch 134 can be inserted into preformed apertures 133 to secure the adaptive seal to bottom edges 222 of leaflets 200 shown in FIGS. 2A and 2C .
  • Cross-stitches around the intersections 118 can increase the strength of an attachment of tubular seal 130 to the expandable member 110 while also allowing for improved load transfer to the expandable member 110 .
  • the cross stitches secure tubular seal 130 at intersections 118 located immediately above (proximal) the inflow crowns 115 .
  • Cross stitches 132 can be formed by passing two stitches 132 a, 132 b of a suture in orthogonal directions over the intersections 118 and through the tubular seal 130 .
  • preformed apertures 131 for cross stitch 132 can be formed in the tubular seal 130 .
  • a portion of the tubular seal 130 that is sutured by cross stitch 132 includes an internal fabric, such as those discussed below.
  • Each cross stitch 132 can be knotted independently. As shown in FIG. 5C , cross stitches 132 each include a separate knot 137 . Additionally, cross stitches 132 can be arranged to not pass through leaflets 200 . Cross stitches 132 can be repeated at a plurality of intersections 118 ( FIG. 5A ) circumferentially around an inflow end of a prosthetic heart valve provided herein such that an entire circumference of tubular seal 130 is securely attached.
  • each intersection 118 immediately adjacent to inflow crowns 115 is sutured to tubular seal 130 via a cross stitch provided herein.
  • the tubular seal stitching pattern provided herein can increase the strength of the attachment between the tubular seal 130 and the expandable member 110 while also allowing for improved load transfer to the expandable member 110 through the use of the plurality of cross stitches.
  • tubular seal 130 of prosthetic heart valve 100 can have various suitable structures, arrangements, or materials that allow tubular seal 130 to be secured to leaflets 200 within prosthetic heart valve 100 .
  • Various suitable structures, arrangements, or materials of tubular seal 130 can be used to allow tubular seal 130 to extend around the outside of expandable tubular member 110 to prevent blood leakage around leaflets 200 .
  • FIG. 6 shows an exemplary mandrel 600 that can be used to construct a tubular seal.
  • the mandrel 600 includes a taper which results in a tubular seal having a slightly smaller diameter proximal end compared to the diameter of the distal end.
  • the diameter of the proximal end can include a diameter reduction of about 3% to about 30% as compared to the diameter of the distal end.
  • the taper allows the tubular seal to be removed from the mandrel with relative ease upon completion of the fabrication process.
  • the smaller proximal diameter of the tubular seal tends to cause the proximal projections to lie more firmly against an anchor element of the replacement heart valve.
  • the surface of the mandrel may be textured to create a tubular seal with a reduced contact area.
  • the mandrel can be textured using a bead blasting process. In combination with the selection of a relatively hard outer layer, a textured seal surface is believed to result in a lower friction surface.
  • FIG. 7A shows a tubular seal 730 that includes an inflow end region 740 and an outflow end region 750 .
  • tubular seal 730 can include a polymeric web.
  • the polymeric web can be a thin film, a porous layer, a mesh-like or net-like structure, or a porous network, e.g., a polymeric matrix.
  • inflow end region 740 of tubular seal 130 can include a polymeric web.
  • inflow end region 740 can be a portion of a polymeric web retaining a fabric.
  • polymeric web can include an elastic material.
  • the polymeric web can include an elastomeric matrix.
  • inflow end region 740 can be secured to bottom edges of a plurality of leaflets at an inflow end of a prosthetic heart valve provided herein, e.g., prosthetic heart valve 100 , and have outflow end region 750 extend around an outer surface of an expandable member (e.g., a braided stent) to restrict blood flow around the leaflets.
  • an expandable member e.g., a braided stent
  • a fabric can be embedded within the polymeric web such that the polymeric web forms a polymeric matrix around the fabric.
  • the polymeric web can include an elastic material.
  • an elastic polymeric web can conform to adjacent surfaces of a prosthetic heart valve provided herein to prove a resilient seal.
  • the elastomeric polymer matrix can furthermore conform to the expandable member as the expandable member changed between a restricted configuration and an expanded configuration.
  • an elastic material can allow the tubular seal to return to its original length when the expandable member returns to the restricted configuration without tearing.
  • tubular seal 130 can include one or more layers of an elastomeric polymer.
  • tubular seal 130 can include a polycarbonate, polyurethane, silicone, polytetrafluoroethylene (PTFE), or a combination thereof.
  • suitable materials include, but are not limited to, natural and synthetic rubbers, including cis-1,4-polyisoprene rubber, styrene/butadiene copolymers, polybutadiene rubber, styrene/isoprene/butadiene rubber, butyl rubber, halobutyl rubber, polyurethane elastomers including elastomers based on both aromatic and aliphatic isocyanates, flexible polyolefins including flexible polyethylene and polypropylene homopolymers and copolymers, styrenic thermoplastic elastomers, polyamide elastomers, polyamide-ether elastomers, ester-ether or ester-ester elastomers, flexible ionomers, thermoplastic vulcanizates, flexible poly(vinyl chloride) homopolymers and copolymers, acrylic polymers, and a combination thereof.
  • natural and synthetic rubbers including cis-1,4-polyis
  • tubular seal 130 can include an aliphatic polycarbonate-based thermoplastic urethane.
  • tubular seal 130 can include an elastomeric polymer having a hardness ranging from 3.07 MPa to 9.9 MPa, or a durometer ranging from 75 Shore A to 75 Shore D using ASTM standard D2240 in force on Jan. 1, 2014.
  • tubular seal 130 can include a polymeric material having the mechanical properties shown in Table I below. Notably, all of the listed ASTM standards refers to the standard in force on Jan. 1, 2014.
  • tubular seal 130 can include attachment structures, e.g., grommets 136 , to improve the attachment of the tubular seal 130 to leaflets 200 and/or expandable member 110 .
  • attachment structures e.g., grommets 136
  • tubular seal 730 can include a fabric retained by a polymeric web such that the fabric reinforces the polymeric web to allow the tubular seal to be secured to a prosthetic heart valve provided herein.
  • inflow end region 740 of tubular seal 730 can include a fabric embedded within an elastomeric material.
  • outflow end region 750 of tubular seal 730 can include a plurality of grommets 732 .
  • the fabric of inflow end region 740 can be a woven material. In some cases, the fabric can have warp threads and/or weft threads.
  • the fabric can be composed of fibers having an average thread diameter from about 0.5 microns to about 50 microns (or from about 0.00002 inches to about 0.002 inches), more preferably from about 20 micron to about 40 microns (or about 0.0008 inches to about 0.002 inches). More preferably, in some cases, the fabric is composed of fibers having a thread diameter of about 27 microns (or about 0.0011 inches).
  • the fabric can include non-elastomeric fibers, or non-elastic fibers.
  • Suitable non-elastomeric fiber materials include, but are not limited to, polyolefins, polyesters such as PES 38/31 manufactured by SaatiTech, and polyamides. More particularly, the polyolefins can include, for example, polyethylenes, polypropylenes, polybutenes, ethylene copolymers, propylene copolymers, butene copolymers, and combinations thereof. Because the fabric can include non-elastic fibers, inflow end region 740 and outflow end region 750 can have different overall elastic properties.
  • the fabric of a tubular seal has a non-linear edge defining an interface 753 between inflow end region 740 and the outflow end region 750 .
  • interface 753 between the inflow end region 740 and the outflow end region 750 can be non-linear due to a non-linear edge of the fabric within inflow end region 740 .
  • the non-linear edge can be sinusoidal 753 .
  • the non-linear edge can be a zigzagged edge 754 , a stepped edge 755 , or a scalloped edge 756 , 772 , 782 .
  • FIGS. 7E and 7F provide alternative embodiments of tubular seals 770 , 780 having scalloped, non-linear edges. As shown, the scalloped, non-linear edges define non-linear circumferential interfaces 772 , 782 between an inflow end region 774 , 784 and an outflow end region 776 , 786 . Interfaces 772 , 782 , as shown in FIGS. 7E and 7F , have a scalloped shape defined by a major radius R a , a minor radius R i , a wavelength ( ⁇ ) and a transition zone length (l).
  • major radius R a can be the radius proximate the inflow end region and minor radius R i can be the radius proximate the outflow end region. In some cases, major radius R a can be the radius proximate the outflow end region and minor radius R i can be the radius proximate the inflow end region. As shown in FIGS. 7E and 7F , major radius R a is larger than the minor R i . In some cases, major and minor radii R a , R i are equal and form a sinusoidal-shaped interface. In some cases, the ratio between major radius Ra and minor radius R i can range from 1:1 to 2:1, 2:1 to 3:1, from 3:1 to 4:1, or from 4:1 to 5:1.
  • a necked region 790 can be formed between minor radius R i and major radius R a .
  • minor radius R i can form bulbous ends, as shown in FIG. 7F , to increase the interface length and improve durability of tubular seal 780 at or near interface 782 .
  • the interfaces described herein provide the benefit of preventing or minimizing tear propagation in the tubular seal while providing sufficient bond strength to maintain the bond between the inflow and outflow end regions of the tubular seal. In some cases, the interfaces described herein can prevent or minimize a tear from propagating further at the interface region by redirecting the tear or by providing a barrier to the tear.
  • the major radius R a and/or the minor radius R i can range from about 1.3 millimeters to about 2.54 millimeters (or about 0.050 inches to about 0.100 inches), from about 1.8 millimeters to about 2.0 millimeters (or about 0.070 inches to about 0.080 inches), from about 2.0 millimeters to about 2.54 millimeters (or about 0 . 080 inches to about 0.100 inches), or from about 2.3 millimeters to about 2.4 millimeters (or about 0.090 to about 0.095 inches).
  • the major radius R a and/or the minor radius R i can range from about 0.51 millimeters to about 0.76 millimeters (or about 0.020 inches to about 0.030 inches), from about 0.76 millimeters to about 1.0 millimeters (or about 0.030 inches to about 0.040 inches), from about 1.0 millimeters to about 1.3 millimeters (or about 0.040 inches to about 0.050 inches), from about 0.51 millimeters to about 1.0 millimeters (about 0.020 inches to about 0.040 inches), or from about 0.51 millimeters to about 1.3 millimeters (or about 0.020 inches to about 0.050 inches).
  • the wavelength ( ⁇ ) of the scalloped-shaped interface can range from about 2.5 millimeters to about 1.0 millimeters (or about 0.10 inches to about 0.40 inches), from about 3.8 millimeters to about 5.1 millimeters (or about 0.15 inches to about 0.20 inches), or from about 5.1 millimeters to about 6.35 millimeters (or about 0.20 inches to about 0.25 inches).
  • the transition zone length can be measured as a distance between the crest of the minor radius R i and the trough of the major radius R a .
  • the transition zone length can range from about 2.8 millimeters to about 3.0 millimeters (or about 0.110 inches to about 0.120 inches), from about 3.0 millimeters to about 3.3 millimeters (or about 0.120 inches to about 0.130 inches), from about 3.3 millimeters to about 3.6 millimeters (or about 0.130 inches to about 0.140 inches), from about 3.6 millimeters to about 3.8 millimeters (or about 0.140 inches to about 0.150 inches), from about 3.8 millimeters to about 4.1 millimeters (or about 0.150 inches to about 0.160 inches), or from about 2.8 millimeters to about 4.1 millimeters (or about 0.110 inches to about 0.160 inches).
  • inflow end region 740 can be thicker than outflow end region 750 because of the presence of a fabric within inflow end region 740 .
  • inflow end region 740 can have a thickness of about 70 microns (0.0028 inches).
  • outflow end region 750 can have a thickness of about 50 microns (about 0.0020 inches).
  • Other suitable thicknesses for inflow end region 740 include thicknesses ranging from about 50 microns to about 90 microns (about 0.0020 inches to about 0.0035 inches), or more preferably, from about 60 microns to about 80 microns (about 0.0025 inches to about 0.0031 inches).
  • Suitable thicknesses for outflow end region 750 include thicknesses ranging from about 30 microns to about 70 microns (about 0.0011 inches to about 0.0028 inches), or more preferably, from about 40 microns to about 60 microns (about 0.0016 inches to about 0.0023 inches). In some cases, suitable thickness ratios of inflow end region 740 relative to outflow end region 750 can range from 1:1 to 1.2:1, from 1.2:1 to 1.4:1, from 1.4:1 to 1.5:1, and from 1.5:1 to 2:1.
  • a non-linear edge can providing a non-linear interface, e.g., interface 753 , between inflow end region 740 and outflow end region 750 .
  • a prosthetic heart valve that has non-linear interface 753 may have an increased overall diameter that tapers more gradually than a prosthetic heart valve that has a linear interface.
  • the non-linear edge of the fabric can gradually transition the change in elastic properties between the outflow end region 750 and inflow end region 740 , mitigating the formation of stress concentrators along an interface that can cause tearing in the tubular member. Additionally, the non-linear shape of interface 753 can minimize or prevent the propagation of tears.
  • the fabric can be arranged in inflow end region 740 to allow for the fabric within inflow end region 740 to stretch in axial and/or radial directions to allow tubular seal 730 to stretch along with an expandable member during implantation.
  • the seal can cause non-uniform crimping during manufacturing or damage the expandable member during device deployment.
  • a woven fabric can be arranged to have the warp and the waft extend in directions oblique to the axis of tubular seal 730 .
  • both the warp and the waft can extend at an angle between 30 degrees and 60 degrees with the axis of tubular seal 730 . In some cases, both the warp and the waft can extend at an angle between 5 degrees and 70 degrees with the axis of tubular seal 730 . In some cases, the warp and waft can be arranged within the tubular member 730 to form an angle of about 45 degrees with the axis of tubular seal 730 .
  • the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions. Limiting the fabric within inflow end region 740 from stretching in a direction oblique to the axis can prevent the fabric from bunching and minimize non-uniform crimping during manufacturing.
  • U.S. Patent Application No. 2013/0090729 which is hereby incorporated by reference in its entirety.
  • U.S. Pat. No. 8,778,020 describes a seal that includes a multilayer, cylindrical seal body having projections alternating with recesses along the proximal edge of the seal body with proximal reinforcing grommets and a distal reinforcing band, which may be formed from a woven or nonwoven fabric and either incorporated within the interior of the multilayer seal body or adhered to the surface thereof.
  • tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include a fabric arrangement that allows a seal to stretch in axial and/or radial directions.
  • elastomeric materials provided herein can be incorporated into the tubular seals disclosed in U.S. Patent Application No. 2013/0090729.
  • the tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include the non-linear interface 753 provided herein.
  • tubular seal 730 can be created by producing one or more layers of elastomeric polymer, applying the fabric and grommets 732 to the one or more layers of elastomeric polymer, and overcoating the fabric and grommets 732 with one or more additional layers of elastomeric material. In some cases, different layers can have different elastomeric properties.
  • tubular seals can include a radially innermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; a radially outermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; and at least one inner layer disposed between the radially outermost layer and a radially innermost layer.
  • the modulus of elasticity of the innermost layer is less than the modulus of elasticity of the radially innermost outer layer and the modulus of elasticity of the radially outermost outer layer.
  • the elongation to break of the inner layer is greater than the elongation to break of the radially innermost outer layer and the elongation to break of the radially outermost outer layer.
  • the radially innermost outer layer and the radially outermost outer layer have been depicted as including the same material, it will be appreciated that they may be compositionally the same or different.
  • multilayer tubular seals provided herein may be formed in a variety of ways.
  • multilayer tubular seals provided herein may be formed by successive applications of a polymer solution to an appropriately shaped mandrel, such as that illustrated in FIG. 6 .
  • the mandrel may be mounted to an appropriate holding fixture in a spray booth.
  • a first coating composition including a carrier and at least one polymer may be applied to the mandrel 600 and subsequently dried to form a first coated mandrel.
  • the first coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
  • the coating composition may be applied as a single layer or multiple layers to achieve the desired dried coating thickness.
  • the grommets 732 ( FIG. 7A ) and the fabric may be positioned on the first coated mandrel by inserting locating pins 620 in apertures 610 in the tapered mandrel 600 of FIG. 6 that align with corresponding perforations 30 provided in the grommets 32 , 34 , 36 and the fabric 40 . In FIG. 6 , only one pin 620 has been illustrated for clarity.
  • the fabric can be cut to a suitable shape having a non-linear edge using any suitable method.
  • the fabric can be die cut.
  • the fabric can be cut with a blade.
  • the fabric can be cut using a femtosecond laser.
  • a femtosecond laser cut fabric mitigates the chances of forming stress concentrators along the edge of the fabric.
  • a second coating composition including a carrier and at least one polymer may be applied to the first coated mandrel, the fabric, and the plurality of grommets.
  • the second coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
  • the carrier of the second coating composition may be removed, thereby forming a second coated mandrel.
  • the second coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness.
  • the second coating composition may be different from the first coating composition.
  • the second coating composition may be composed of the same material as the first coating composition.
  • a third coating composition including a carrier and at least one polymer may be applied to the second coated mandrel.
  • the third coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
  • the carrier of the third coating composition may be removed thereby forming a tubular seal precursor.
  • the third coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness.
  • the third coating composition may be different from the first coating composition.
  • the third coating composition may be the same as the first coating composition.
  • the third coating composition may be different from the second coating composition.
  • the third coating composition may be the same as the second coating composition.
  • the tubular seal precursor may be inspected to ensure that it is fully formed and meets dimensional specifications, such as a thickness specification.
  • a suitable thickness for the tubular seal precursor can range from about 30 microns to about 75 microns (about 0.001 inches to about 0.0030 inches) or from about 50 microns to about 120 microns (about 0.002 inches to about 0.0047 inches).
  • tubular seal precursor examples include a range from about 20 microns to about 40 microns (about 0.0008 inches to about 0.002 inches), about 30 microns to about 50 microns (about 0.001 inches to about 0.002 inches), about 50 microns to about 75 microns (about 0.002 inches to about 0.0029 inches), about 50 microns to about 100 microns (about 0.002 inches to about 0.004 inches), about 100 microns to about 120 microns (about 0.004 inches to about 0.0047 inches), about 100 microns to about 150 microns (about 0.004 inches to about 0.0059 inches), about 150 microns to about 200 microns (about 0.0059 inches to about 0.0079 inches), as well as any thickness value within any of the listed ranges.
  • the tubular seal precursor may be inspected to ensure that it meets certain functional specifications, e.g., tensile and frictional specifications.
  • the tubular seal precursor may then be trimmed by laser cutting, or blade cutting, to conform to dimensional specifications and removed from the tapered seal-forming mandrel as a formed tubular seal.
  • at least some preformed apertures for suturing tubular seal to expandable member 110 and/or leaflets 200 can be performed by laser cutting.
  • at least some of the grommets may be formed by a laser cutting operation performed on a tubular seal precursor.
  • 7A may be added to the multilayer, generally cylindrical seal, in a step not illustrated, as a proximal band. Subsequent laser cutting of the tubular seal precursor would then simultaneously form grommets 732 by removing the portions of the proximal band located between the projections.
  • coating compositions may be selected to provide a relatively stiff dried polymer such as a dried polymer having a Shore D hardness of about 55, or a hardness of about 6.21 Megapascals (MPa).
  • coating compositions may be selected to provide a relatively elastomeric dried polymer such as a dried polymer having a Shore A hardness of about 80, or a hardness of about 3.45 MPa.
  • the first and third dried polymer layers may have a Shore D hardness of 55, or a hardness of 6.21 MPa
  • the second layer may have a Shore A hardness of 80, or a hardness of 3.45 MPa.
  • the plurality of grommets and the fabric can be positioned between the first and second coating layers. In some cases, the plurality of grommets and the fabric can be positioned elsewhere within the tubular seal, e.g., within a layer, or on the radially innermost or radially outermost surface of the tubular seal.
  • a tubular seal 760 can include a woven or non-woven fabric embedded throughout a polymer or metal matrix structure.
  • at least one leaflet of the heart valve can be secured to the tubular seal in a portion of the tubular seal including the woven or non-woven fabric to minimize blood leakage between the tubular seal and the leaflets.
  • FIGS. 8A-8C are illustrations of an exemplary tubular seal 800 secured to an exemplary prosthetic heart valve provided herein.
  • Tubular seal 800 as shown in FIGS. 8A-8C , includes a non-linear edge interface 820 between an inflow end region 840 and an outflow end region 750 .
  • FIG. 8A shows tubular seal 800 advancing from a distal end of a deployment device provided herein and expanding radially.
  • FIG. 8B provides an illustration of tubular seal 800 in a further radially expanded and deployed state.
  • FIG. 8C provides a close up illustration of non-linear interface 820 of tubular seal 800 .
  • tubular seal 800 includes a fabric in inflow end region 840 that has a non-linear edge defining a non-linear circumferential interface 820 between inflow end region 840 and outflow end region 850 .
  • the non-linear edge of the fabric forms a scalloped-shaped interface 820 .
  • the non-linear edge can form a sinusoidal, scalloped, or zigzagged shaped interface.
  • the non-linear interface between inflow end region 840 and outflow end region 850 can disperse stress that forms along the interface during stretching of the tubular seal, limit or redirect tear propagation in outflow end region 850 back towards inflow end region 840 , and provide a transition zone where the overall outer diameter of the tubular member transitions between a thinner outflow end region thickness to a thicker inflow end region thickness. Variations in thickness between inflow end region 840 and outflow end region 850 can be due to the presence of the fabric within inflow end region 840 .
  • a tubular seal having a non-linear interface can exhibit a different tensile failure mode than a tubular seal with a linear interface, because the tear propagation has been limited or redirected at interface 820 .
  • Advantages of having non-linear interface 820 thus includes increasing the durability of tubular seal 800 at interface 820 .
  • prosthetic heart valves provided herein include a tubular seal including a woven fabric within an elastomeric matrix where the woven fabric has a non-linear edge within the elastomeric matrix around the circumference of the tubular seal.
  • the matrix structure can be made of elastomeric material.
  • tubular seal 800 can be made of the fabric alone.
  • non-elastic fibers 860 can be part of a knit fabric used in tubular seals provided herein.
  • the fabric is a woven or nonwoven fabric having non-elastic fibers 860 arranged to allow the seal radially expand.
  • the fabric can, for example, include non-elastic fiber 860 arranged to allow a portion of tubular seal 800 to stretch in axial and/or radial directions relative to the axis of the tubular seal 800 .
  • the woven fabric having non-elastic fiber 860 can be positioned along a front edge of a tubular seal positioned to be secured to an expandable member.
  • the non-elastic fiber 860 can be arranged at an of between 5 degrees and 70 degrees relative to a central axis of the tubular seal such that the non-elastic fiber 860 allow for a limited stretching of the tubular seal in an axial direction and/or a radial direction.
  • the non-elastic fiber 860 can be part of a woven fabric having fiber in a warp direction and fibers in a waft direction each oriented at an angle of between 5 degrees and 70 degrees relative to a central axis of the tubular seal.
  • the non-elastic fiber 860 do not individually stretch, a woven structure can be stretched in directions non-parallel with the orientation of the fiber 860 .
  • the non-elastic fiber 860 can be arranged within the tubular member 760 to form an angle of about 45 degrees with the axis of the tubular seal.
  • the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions.
  • fibers 860 of the fabric can allow for the expandable member to be secured to the leaflets and/or to the expandable member.
  • stitches or sutures can extend around the non-elastic fiber 860 within the matrix to ensure that the stitches or sutures do not cause the tubular seal to tear. Tears in the tubular seal can result in leakage of blood past a prosthetic heart valve, which can result in heart failure.
  • the non-elastic fiber 860 within the tubular seal can be dispersed throughout a matrix structure, e.g., an elastomeric polymer matrix.
  • a fabric of the non-elastic fiber 860 can be throughout the tubular seal.
  • the fabric within the matrix, e.g., an elastomeric polymer matrix, can be arranged to allow for a limited amount of expansion of the tubular seal in a radial direction and/or an axial direction.
  • non-elastic fiber 860 dispersed throughout the tubular seal can simplify the production of the tubular seal, allow for sutures to be used to attach any section of the tubular seal to one or more other portions of a prosthetic heart valve provided herein, and provide a substantially uniform thickness.
  • a tubular seal having a uniform thickness can facilitate loading of a prosthetic heart valve provided herein into a delivery sheath because non-uniform sections of a seal can catch on a delivery sheath and potentially tear the tubular seal.
  • a tubular seal provided herein can include an inflow end region and an outflow end region with the inflow end region including a fabric of non-elastic fiber 860 .
  • the inflow end region can be secured to the bottom edges of leaflets and/or an inflow end of the expandable member by stitches and/or sutures.
  • an outflow end region can include grommets for attachment to an outer surface of the expandable member.
  • the fabric can be arranged to allow for the inflow end region to be expanded in a radial and/or axial direction, which can mitigate the transition in elasticity at the interface between an inflow end region and the outflow end region.
  • An abrupt transition in elasticity between the inflow end region and the outflow end region can result in a stress concentrator along the interface, which can result in a tear along the interface.
  • the fabric can be made of polymeric materials that include, but are not limited to, polyesters, polyolefins such as polyethylene and polypropylene, polyamides, nylons, and combinations thereof.
  • the fabric can have a thickness ranging from about 40 to about 80 microns (about 0.002 inches to about 0.003 inches).
  • the fabric can be woven such that spacings between individual fiber 860 create openings in the fabric that together constitutes from about 20% to about 40% of a fabric surface.
  • tubular seal 800 can be created by coating a continuous tube of fabric including non-elastic fiber 860 with an elastomeric polymer and cutting the tube into individual tubular seals or portions of tubular seals.
  • portions of the tubular seal having fabric can be created on a separate mandrel and later bonded to portions of the tubular seal that do not have fabric.
  • a tube of fabric can be stretched in an axial direction during the coating of the fabric with the elastomeric polymer to enable the tubular seal to have more stretch in a radial direction than an axial direction.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

A tubular seal includes an outflow end region and an inflow end region. The inflow end region is a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.

Description

    RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 16/139,256, filed Sep. 24,2018, which is a continuation of U.S. application Ser. No. 15/059,840, filed Mar. 3, 2016, which claims priority to U.S. Provisional Application No. 62/133,048, filed Mar. 13, 2015.
  • FIELD
  • This document provides prosthetic heart valves having an improved tubular seal.
  • BACKGROUND
  • The human heart contains four valves: a tricuspid valve, a pulmonic valve, a mitral valve and an aortic valve. The main purpose of the valves is to maintain unimpeded forward flow of blood through the heart and the major blood vessels connected to the heart, for example, the pulmonary artery and the aorta. As a result of a number of disease processes, both acquired and congenital, any one of the four heart valves may malfunction and result in either stenosis (impeded forward flow) and/or backward flow (regurgitation). Either process burdens the heart and may lead to serious problems, for example, heart failure. Various procedures for fixing or replacing defective heart valves are known in the art. In some cases, artificial heart valves can be implanted in the heart of a patient to replace a diseased or damaged heart valve with a prosthetic equivalent to minimize stenosis and regurgitation.
  • Prosthetic heart valves can have a variety of designs. Two major types of prosthetic heart valves include mechanical heart valves and bioprosthetic heart valves. Mechanical heart valves can be made of synthetic materials, such as plastics or metals, while bioprosthetic heart valves can be made of biologic tissue mounted on a fabric covered plastic or metal frame. Bioprosthetic heart valves can include animal tissue, such as porcine or bovine tissue, that has been chemically treated to make the valve suitable for implantation in a human. Bioprosthetic valves do not generally require a patient to undergo anticoagulant therapy, which is typically required when using mechanical valves. But bioprosthetic valves can be more prone to device wear such as tears in the valve tissue that may require the valve to be replaced. There is therefore a need to further improve the design of bioprosthetic valves to retain its functionality during the life of the patient.
  • SUMMARY
  • Prosthetic heart valves provided herein can have a structure adapted to retain functionality during the life of the patient and to minimize stenosis and regurgitation by having an improved connection between different parts of the prosthetic heart valve.
  • In Example 1, a tubular seal includes an outflow end region and an inflow end region. The inflow end region can include a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.
  • In Example 2, the tubular seal of Example 1, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
  • In Example 3, the tubular seal of Example 1 or Example 2, wherein the woven fabric includes non-elastic fibers.
  • In Example 4, the tubular seal of Example 1-3, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
  • In Example 5, the tubular seal of Example 4, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
  • In Example 6, the tubular seal of Example 4, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
  • In Example 7, the tubular seal of one of Examples 1-6, wherein the interface of the woven fabric has a scalloped shape.
  • In Example 8, the tubular seal of Example 7, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
  • In Example 9, the tubular seal of Example 7, wherein the interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
  • In Example 10, the tubular seal of Example 7, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
  • In Example 11, a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix. The woven fabric can include a non-linear edge within the elastomeric polymer matrix.
  • In Example 12, the tubular seal of one of Example 11, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
  • In Example 13, the tubular seal of one of Examples 11 or 12, wherein the non-elastic fibers include a polyester.
  • In Example 14, the tubular seal of one of Examples 11-13, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
  • In Example 15, the tubular seal of one of Examples 11-14, wherein the inflow end region includes a first substantially uniform thickness and an outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • In Example 16, a prosthetic heart valve includes an expandable tubular member, a plurality of leaflets and a tubular seal. The plurality of leaflets can be secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member. The tubular seal can include a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member. The tubular seal can include an outflow end region and an inflow end region. The inflow end region can be a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
  • In Example 17, the prosthetic heart valve of Example 16, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
  • In Example 18, the prosthetic heart valve of Example 16, wherein the woven fabric includes the non-elastic fibers.
  • In Example 19, the prosthetic heart valve of Example 18, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
  • In Example 20, the prosthetic heart valve of Example 19, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
  • In Example 21, the prosthetic heart valve of Example 19, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
  • In Example 22, the prosthetic heart valve of Example 16, wherein the woven fabric includes non-elastic fibers arranged in the polymeric web to allow the tubular seal to stretch in axial and radial directions.
  • In Example 23, the prosthetic heart valve of Example 16, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
  • In Example 24, the prosthetic heart valve of Example 16, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • In Example 25, the prosthetic heart valve of Example 16, wherein the outflow end region includes a plurality of grommets.
  • In Example 26, a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric that includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix. The woven fabric includes a non-linear edge within the elastomeric polymer matrix.
  • In Example 27, the tubular seal of Example 26, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape defining an interface between the inflow end region and the outflow end region.
  • In Example 28, the tubular seal of Example 27, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
  • In Example 29, the tubular seal of Example 27, wherein interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
  • In Example 30, the tubular seal of Example 27, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
  • In Example 31, the tubular seal of Example 26, wherein the non-elastic fibers include a polyester.
  • In Example 32, the tubular seal of Example 26, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
  • In Example 33, the tubular seal of Example 26, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
  • In Example 34, the tubular seal of Example 26, wherein a thickness for the inflow end region ranges from about 0.0016 inches to about 0.0023 inches, or from about 40 microns to about 60 microns.
  • In Example 35, a method includes forming at least a portion of a tubular seal that includes a woven fabric within a matrix by dipping a mandrel with a first coating composition that includes at least one elastomeric polymer. The method can also include drying the first coating composition and positioning the woven fabric on the mandrel such that fibers within the fabric are oriented at an angle of about 45 degrees with respect to a central axis of the tubular seal. The method can further include applying a second coating composition on the mandrel, the second coating composition being different than the first coating composition and removing the tubular seal from the mandrel.
  • Prosthetic heart valves provided herein can additionally have a reduced unexpanded profile. In some cases, prosthetic heart valves provided herein include a plurality of anchor elements. In some cases, anchor elements can be secured to an expandable tubular member. In some cases, the expandable tubular member can be a braided stent. In some cases, prosthetic heart valves provided herein include three or more leaflets. In some cases, the leaflets can have a body portion and sleeve portions one or both sides. In some cases, sides of the body portions can be secured together and sleeve portions secured to anchor elements (e.g., anchor elements attached to a braided stent). In some cases, prosthetic heart valves provided herein can include a tubular seal. In some cases, the tubular seal can be secured to bottom edges of body portions of the leaflets. In some cases, the seal can be secured to a blood inlet side of an expandable member.
  • Although tubular seals provided herein can be applied to a variety of prosthetic heart valves provided herein (and within the scope of the claims), additional details about the overall structure of an exemplary prosthetic heart valve are provided below.
  • The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
  • DESCRIPTION OF DRAWINGS
  • FIGS. 1A-1I illustrate an exemplary prosthetic heart valve and an exemplary deployment device provided herein. FIGS. 1A and 1B are perspective views of the heart valve provided herein connected to the deployment device. FIG. 1C is a side view of the exemplary prosthetic heart valve. FIGS. 1D-1I illustrate how the exemplary heart valve provided herein can be delivered by the deployment device.
  • FIGS. 2A-2C illustrates an exemplary leaflet, which can be used in prosthetic heart valves provided herein. FIG. 2A illustrates a rounded notch in a leaflet where a leaflet can be secured to an adjacent leaflet. FIGS. 2B and 2C illustrate a side portion of the exemplary leaflet. FIG. 2B depicts the rounded notch in an armpit of the exemplary leaflet. FIG. 2C depicts attachment elements in the armpit of the exemplary leaflet.
  • FIG. 3 illustrates another exemplary leaflet, which can be used in prosthetic heart valves provided herein. FIG. 3 depicts apertures in a body of the exemplary leaflet.
  • FIGS. 4A-4G illustrate how adjacent leaflets can be stitched together in prosthetic heart valves provided herein.
  • FIGS. 5A-5C illustrate a cross stich provided herein for connecting a seal to a braided stent in an exemplary prosthetic heart valve provided herein. FIG. 5A shows a front view of a seal having apertures and stitch patterns used for securing the seal to the braided stent. FIG. 5B depicts a close up view of a cross stitch and a portion of a circumferential stitch used for securing the seal to the braided stent. FIG. 5C depicts a cross-sectional view showing the cross stitch and a portion of the circumferential stitch.
  • FIG. 6 depicts an apparatus that can be used to form a tubular seal provided herein.
  • FIGS. 7A-7G illustrate exemplary tubular seals that include a fabric having a non-linear edge positioned within a polymeric web or matrix in a prosthetic heart valve provided herein.
  • FIGS. 8A-8C illustrate an exemplary tubular seal having a scalloped, non-linear edge in a prosthetic heart valve provided herein.
  • Like reference symbols in the various drawings indicate like elements.
  • DETAILED DESCRIPTION
  • FIGS. 1A and 1B illustrate an exemplary prosthetic heart valve 100 provided herein. FIGS. 1A and 1B are perspective views of prosthetic heart valve 100 connected to a deployment device 190. FIG. 1C is a side view of prosthetic heart valve 100. As shown in FIGS. 1A-1C, prosthetic heart valve 100 includes an expandable member 110, three leaflets 200, three anchor elements 120 that secure sleeve portions 216 of leaflets 200 to expandable member 110, and a tubular seal 130 secured around a blood inflow end of prosthetic heart valve 100. To facilitate better understanding, FIG. 1A does not show components that are located underneath tubular seal 130, but FIG. 1B does show these components since tubular seal 130 can be made of transparent materials that would normally allow these components to be visible. Anchor elements 120 can include post leg compression elements 122 and clamping support structures 126 adapted to provide support along opposite sides of the sleeve portions 216. Expandable member 110 in
  • FIGS. 1A-1I is a braided stent (which can also be described as a braided anchor element), which is adapted to transition between a restricted state having a smaller diameter and an expanded state having a larger diameter. Expandable member 110 can be self-expanding, mechanically expanded, or a combination thereof
  • FIGS. 1D-1I depict how an exemplary heart valve delivery system 180 can deliver and deploy prosthetic heart valve 100 provided herein within a blood vessel. System 180 can include a sheath 182 for retaining prosthetic heart valve 100 with the expandable member 110 in a restricted state. Tubular seals provided herein can have a uniform thickness or a thickness that has a non-linear interface between an inflow end region and an outflow end region to provide a transition zone between a thinner outflow end region to the thicker inflow end region that facilitates loading of prosthetic heart valve 100 into sheath 182. For example, a substantially uniform thickness or a transition zone can reduce the probability for sections of the tubular seal to catch on an outer rim of sheath 182 during loading of prosthetic heart valve 100 in a restricted state. Additionally, tubular seals provided herein can allow for radial and/or axial expansion of the tubular seal in portions including non-elastic fibers, accordingly, a tubular seal used in prosthetic heart valves provided herein can have a non-expanded diameter that expands to the predetermined outer diameter of the expandable member and that stretches to an axially elongated but radially restricted configuration when prosthetic heart valve 100 is in a restricted state to further reduce the profile of prosthetic heart valve 100 within sheath 182.
  • Within sheath 182, anchor elements 120 (FIGS. 1A-1C) can be connected to pushing prongs 192 and a pull line 194 can be connected to a nose cap 196, or end cap, which is positioned at the end of sheath 182. As shown in FIGS. 1A and 1B, the pull line 194 can extend through expandable member 110 and through the valve opening between the leaflets 200. As shown by FIGS. 1D-1I, once a distal end of sheath 182 is delivered through the circulatory system to an appropriate location (e.g., within the heart), prosthetic heart valve 100 can be deployed. By advancing pushing prongs 192 and pull line 194 relative to sheath 182, prosthetic heart valve 100 can be pushed out of sheath 182. In some cases, expandable member 110 can self-expand upon exiting sheath 182. In some cases, expandable member 110 can self-expand to a first intermediate diameter, and system 180 can mechanically expand expandable member 110 to a larger deployment diameter. For example, anchor elements 120 can include a locking mechanism to clip a portion of expandable member when the expandable member 110 is expanded to a predetermined locking diameter. In some cases, system 180 can mechanically expand expandable member 110 to a predetermined locking diameter. In some cases, system 180 can compress expandable member 110 between pushing prongs 192 and nose cap 196 by moving pull line 194 relative to pushing prongs 192. The predetermined locking diameter can be adapted to set the diameter of prosthetic heart valve 100 during implantation. After prosthetic heart valve 100 is set, system 180 can move pull line 194 and nose cap 196 relative to pushing prongs 192 to move the end cap through the opening between leaflets 200 in prosthetic heart valve 100. Pushing prongs 192 can then be retracted from anchor elements 120 and retracted into sheath 182. In some cases, pushing prongs 192 can include a shape member material adapted to help radially expand expandable member 110 as the expandable member 110 exits sheath 182. A control handle 188 can be used to control the relative movements of sheath 182, pushing prongs 192, and pull wire 194. Prosthetic heart valves provided herein can be adapted to mitigate damage that may occur to valves during delivery and implantation.
  • In some cases, one or more radiopaque markers can be secured to prosthetic heart valves provided herein. As shown in FIGS. 1A-1C, expandable member 110 includes a radiopaque marker 112. Any suitable radiopaque material (such as platinum, palladium, gold, tantalum, or alloys thereof) can be used as the radiopaque material in radiopaque marker 112. One or more radiopaque markers can be used with an imaging system to help a physician ensure that a valve is set in an appropriate location. In some cases, prosthetic heart valves provided herein include at least three radiopaque markers.
  • Referring to FIGS. 1A and 1B, prosthetic heart valve 100 can include a plurality of leaflets 200. In some cases, as shown, prosthetic heart valve 100 includes three leaflets 200. In some cases, prosthetic heart valves provided herein can have any suitable number of leaflets, such as two, three, four, five, or more leaflets. In some cases, leaflets 200 are secured to one another. In some cases, leaflets 200 can be secured to one another by a suture (not shown) or a plurality of sutures. Leaflets 200 can be sutured alongside edges of a body portion of each leaflet. In some cases, prosthetic heart valves provided herein can include a single line of sutures, which can be adapted to minimize leaks, minimize the width of a seam, and/or minimize the profile of a replacement heart valve during a percutaneous insertion. In some cases, prosthetic heart valves provided herein can include multiple lines of sutures.
  • Expandable member 110 can have any suitable structure, arrangement, or material. In some cases, expandable member 110 can include a braided wire stent. For example, U.S. Publication Number 2005/0143809, titled, “Methods and Apparatus for Endovascularly Replacing a Heart Valve,” and filed on Nov. 5, 2004, which is herein incorporated by reference for its disclosure of possible structures and materials for a braided wire stent, discloses a braided wire stent. In some cases, expandable member 110 includes a shape memory material (e.g., a nickel-titanium alloy or a cobalt-chromium alloy).
  • FIGS. 2A-2C provide illustrations of an exemplary leaflet 200 that includes a body portion 214 and sleeve portions 216. In some cases, body portion 214 has a bottom edge 222, a first side edge 226, a second side edge 228, and a free edge 224. Leaflet 200 further includes a front (i.e., a side facing the blood inflow end of a prosthetic heart valve), a back (i.e., a side facing the blood outflow end), a first side adjacent to the first side edge 226, and a second side adjacent to the second side edge 228. In some cases, the front of leaflet 200 has a different texture than the back. In some cases, the back or front can have a non-textured or textured surface to mitigate calcium buildup on the surfaces. For example, in some cases, the back of leaflet 200 may be prone to calcium build due to a cusp-shaped, concave surface, thus it can be beneficial to have a textured surface on the back of leaflet 200 to mitigate calcification issues. Leaflets can be made of various synthetic or non-synthetic materials. In some cases, the leaflet 200 is made from tissue obtained from an animal, e.g., a pig or a cow. In some cases, leaflet 200 is made from bovine pericardium. In some cases, leaflets 200 can be made from a synthetic polymers or composites. Leaflets 200 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 200 and stitching the leaflets 200 together along stitch line 246, which is shown in FIG. 2C.
  • Still referring to FIGS. 2A-2C, leaflet 200 defines at least one notch 232, 234 between at least one of the two side edges 226, 228 and a corresponding adjacent sleeve portion 216. Each notch 232, 234 can be located along side edges 228, 226 at a location adjacent to the sleeve portions 216, e.g., at an “armpit” of leaflet 200 as depicted in FIGS. 2A and 2B. In some cases, leaflet 200 can define a notch along the length of side edges 228, 226. In some cases, a notch can be defined along sleeve portion 216. In some cases, multiple notches can be located along sleeve portion 216, side edges 228, 226, and/or at the armpit of the leaflet 200.
  • As shown in FIGS. 2A and 2B, body portion 214 of leaflet 200 has a conical frustum shape defined by bottom edge 222, first side edge 226, second side edge 228, and free edge 224. Other suitable shapes for the body portion can include, but are not limited to, for example, a generally square, rectangular, triangular or trapezoidal shaped body portion.
  • The sleeve portions 216, as shown in FIGS. 2A-2C, can extend outwardly from the body portion 214 of the leaflet 200. Each sleeve portion 216 can oriented at an angle relative to a portion of the body portion, e.g., free edge 224 of body portion 214. Sleeve portions 214, as shown, can be generally rectangular-shaped extensions with lateral free ends. In some cases, sleeve portions 214 can have rounded free ends.
  • Still referring to FIGS. 2A-2C, notches 232, 234 can be generally U-shaped. Other suitable notch shapes can include, but are not limited to, a V-shaped, rectangular-shaped, oval-shaped, and circular notch. In some cases, notches 232, 234 can have rounded edges to smooth the transition between a notch 232, 234 and side edges 228, 226 of leaflet 200. Notches 232, 234 can have a length dimension that can range from about 0.5 millimeters (mm) to about 4 mm (from about 0.02 inches to about 0.20 inches).
  • Referring to FIG. 2C, notches 232, 234 can be shaped and sized to accommodate attachment of post leg compression elements 122. Post leg compression elements 122 can be a part of anchor elements 120 (shown in FIGS. 1A-1C) that compress and restrain sleeve portions 216 along the same line as the stitch line 246. As shown in FIG. 2C, suture 258 can be used to apply an appropriate and consistent compressive force between post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of leaflets 200. Since suture 258 pass through notches 232, 234, it does not need to pass through body portion 214 at or near the armpit of leaflet 200. Sutures that pierce the body portion at or near the armpit of the leaflet can pull, stretch and abrade surrounding tissue areas, creating stress concentrations at or near the armpit of the leaflet. These stress concentrators can result in tears forming in the leaflet. The use of notches 232, 234 with post leg compression elements 122, therefore can minimize potential heart valve tearing that might be caused by sutures at or near the armpit location. Notches 232, 234 create enlarged openings that suture 258 can pass therethrough without pulling or stretching the adjacent tissue. Accordingly, a notched leaflet 200 can improve valve opening capabilities and the reliability of prosthetic heart valves provided herein.
  • FIG. 3 illustrates another exemplary leaflet 300, which can be used in prosthetic heart valves provided herein. As shown in FIG. 3, leaflet 300 can include a body portion 314 and at least two opposite sleeve portions 316. The body portion 314 can be defined by at least two side edges 326, 328 adjacent each sleeve portion 316. Leaflet 300 can define two apertures 332 and 334. Each aperture 332, 334 can be positioned adjacent side edges 326, 328 and the corresponding adjacent sleeve portion 316.
  • Still referring to FIG. 3, body portion 314 has a bottom edge 322, a first side edge 326, a second side edge 328, and a free edge 324. Leaflet 300 further includes a front, a back, a first side adjacent to the first side edge 326, and a second side adjacent to the second side edge 328. Leaflets 300 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 300 and stitching the leaflets 300 together along stitch line 246, as shown in FIG. 2C.
  • As shown in FIG. 3, leaflet 300 defines apertures 332 and 334 adjacent side edges 328, 326 and adjacent one of the sleeve portions 316. Apertures 332 and 334 can be generally circular in shape. Other suitable aperture shapes can include, but are not limited to, for example, a rectangular, oval, triangular, or diamond-shaped aperture. In some cases, apertures 332, 334 can have a length dimension or a diameter from about 0.5 mm to about 4 mm (or about 0.02 inches to about 0.20 inches). In some cases, one or more apertures 332, 334 can be located in the side edges 328, 326 and/or the sleeve portions 316 of the leaflet 300. In some cases, multiple apertures can be located in a region that is adjacent to the side edges 328, 326 and the sleeve portions 316.
  • Apertures 332, 334 in the leaflets 300 can allow one leaflet to be secured to an adjacent leaflet. Similar to the notches discussed above, apertures 332 and 334 can be shaped and sized to accommodate attachment of post leg compression elements 122. Referring back to FIGS. 1A-1C, post leg compression elements 122 can be a part of anchor elements 120 that compress and restrain sleeve portions 216 along the same line as the stitch line 246. A suture 258 can be used to apply an appropriate and consistent compressive force between the post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of the leaflets 200. As already discussed herein, sutures that pierce the body portion 214 at or near the armpit of the leaflet can create stress concentrations at or near the armpit of the leaflet that may result in tearing. Apertures 332 and 334 and post leg compression elements 122, however, can minimize this potential tearing caused by sutures near the armpit location by being positioned proximate to the post leg compression elements near the armpit. Apertures 332, 334 create enlarged openings that allow suture 258 to pass therethrough without pulling or stretching adjacent tissue areas. Accordingly, leaflets 300 used in prosthetic heart valves provided herein can improve the reliability of prosthetic heart valves.
  • FIGS. 4A-4G depict how leaflets 200 can be connected (or jointed) with an improved stitch discussed herein. As shown, stitch 446 can be a single continuous line stitch traveling along a stitch line in a forward direction and back in a reverse direction. In some cases, stitch 446 can run along a leaflet from a bottom edge to a side edge of the leaflet (e.g., bottom edge 222 to side edge 226 of leaflet 200 in FIG. 2A-2B). In some cases, stitch 446 can run from a side edge to a notch of a leaflet (e.g., side edge 226 to notch 234 of leaflet 200 in FIG. 2A-2B).
  • As shown in FIGS. 4D-4G, stitch 446 can include a plurality of perpendicular loop segments 434 extending through an aperture in the two leaflets, around outer side edges of the two attached leaflets, and back through the aperture. Stitch 446 can include a plurality of parallel segments 436 extending between adjacent apertures along the stitch line. Stitch 446 can include two perpendicular loop segments 434 extending through apertures formed in the stitch line. In some cases, a first perpendicular loop segment 434 for a first aperture in the stitch line is formed when the stitch is formed in the forward direction and a second perpendicular loop segment 434 for the first aperture is formed in the reverse direction. In some cases, parallel segments 436 made in a forward direction alternate between opposite sides of the two leaflets between each aperture in the stitch line. In some cases, parallel segments 436 made in a reverse direction are formed on an opposite side of the two leaflets from parallel segments 436 made in a forward direction. In some cases, opposite parallel segments 436 made in the forward and reverse directions can provide a continuous compressive force along the entire length of the stitch line. Perpendicular loop segments 434 can provide compressive force to reinforce a seal formed between the two leaflets along the stitch line.
  • Stitch 446 can include any appropriate number of perpendicular loop segments formed through any appropriate number of apertures. As shown, stitch 446 includes six perpendicular loop segments formed through six apertures (two perpendicular loop segments per aperture). In some cases, stitch 446 can include up to twelve perpendicular loop segments formed through six or more apertures. In some cases, a stitch connecting side edge segments of leaflets can be formed using between 3 and 20 apertures and include between 3 and 40 perpendicular loop segments. In some cases, apertures can be positioned from about 0.2 mm to about 10 mm apart (or about 0.008 inches to about 0.4 inches apart). In some cases, apertures can be positioned from about 0.2 mm to about 10 mm (or about 0.008 inches to about 0.4 inches) away from the side edges of the leaflets.
  • Stitch 446 can be formed in a process depicted in FIGS. 4A-4G. As shown in FIG. 4A, a thread needle 410 can be passed through aligned leaflet side edges 226 a and 226 b to create a first aperture at a location near bottom edges 222, e.g., a location approximately 1 mm from the bottom edges 222. The leaflet side edges 226 a and 226 b can be retained in a desired configuration by clamping the leaflets between clamp sides 422 and 424. Needle 410 pulls a leading end 431 of a thread 432 through the first aperture. As shown in FIG. 4B, needle 410 can then form a second aperture adjacent to the first aperture along the stitch line (towards the leaflet sleeve portion) about 0.5 mm away from the first aperture to pull leading end 431 of thread 432 through the second aperture to form a first parallel segment. As shown in FIG. 4C, a perpendicular loop segment 434 can be made by guiding needle 410 around the leaflet side edges and re-enter the second aperture from a backside. Thread 432 can be pulled through the second aperture until it sits firmly against the leaflet material (e.g., leaflet pericardium tissue). FIG. 4D shows a second parallel segment, which can be made by pushing needle 410 through leaflet tissue along the stitch line to form a third aperture approximately 1 mm from the second aperture (towards the sleeve segments of the leaflet). As shown in FIG. 4E, a second perpendicular loop segment 434 can be formed by again having needle 410 loop around the leaflet side edges and reenter the third aperture through the backside. This is repeated up to notch 234 to form a total of six parallel segments 436 and six perpendicular loop segments 434 in a forward direction, as shown in FIG. 4F. The stitch pattern can then be repeated in a reverse direction towards the bottom edges 222 of the leaflets through the previously formed apertures. Accordingly, each aperture can include two perpendicular loop segments 434 and parallel segments on the opposite sides can be formed from the parallel segments that were created in the forward direction, as shown in FIG. 4G. The method and stitches depicted in FIGS. 4A-4G can be applicable to leaflets 200, 300 discussed herein.
  • Stitch 446 and other stitches provided herein can improve the reliability of a seal formed along a stitch line, create fewer apertures through the leaflets, and simplify the stitching operation. Having fewer apertures can help minimize the occurrence of blood leakage through the apertures. The single continuous line of stitch 446 using a single row of apertures can minimize a width of a side edge portion needed to form a continuous seal along the side edges of the leaflets, thus providing a reduced restricted profile for prosthetic heart valves provided herein. For example, U.S. Pat. No. 8,778,020 describes a variety of ways that leaflets can be sutured together using combinations of whip stitches and running stitches, but these stitches require additional apertures and multiple lines. Perpendicular loop segments 434 can stitch a plurality of leaflets together, similar to the whip stitches discussed in U.S. Pat. No. 8,778,020. Parallel segments 436 can secure valve leaflets to one another, similar to the running stitches discussed in U.S. Pat. No. 8,778,020. Although stitch 446 can provide an improved attachment between side edges of leaflets in prosthetic heart valves provided herein, some embodiments of prosthetic heart valves provided herein can use other stitch patterns, such as those described in U.S. Pat. No. 8,778,020, which is hereby incorporated by reference.
  • Important characteristics of a suture thread can include, but are not limited to, adequate tensile strength, abrasion resistance and creep rupture resistance characteristics that allow the device to be delivered into and sustain implantation within a human anatomy. The thread used for suturing together portions of the heart valve, e.g., side edges of the leaflets, can be composed of biocompatible materials that include, but are not limited to, polyethylene such as ultra high molecular weight polyethylene (UHMWPE), polyester (PET), and a combination thereof.
  • Referring back to FIGS. 1A-1C, tubular seal 130 of prosthetic heart valve 100 can be secured to bottom edges 222 (FIG. 2A) of body portion 214 of leaflet 200 by a circumferential running stitch 134. In some cases, tubular seal 130 can be secured to expandable member 110 by fasteners, such as grommets 136, and extended around the outside of expandable member 110 to provide a seal that minimizes blood leakage around the leaflets 200 of an implanted prosthetic heart valve 100. The structure and materials of tubular seal 130 are further discussed with reference to FIGS. 6 and 7A-7E.
  • FIGS. 5A-5C provide an improved tubular seal stitching pattern can include a cross stitch 132 between tubular seal 130 and expandable member 110. For example, a blood inlet side of expandable member 110 (e.g., braided anchor element) can be secured to a portion of the tubular seal having the woven fabric by a plurality of stitches (e.g., a plurality of cross stitches securing the seal to two crossing members of a braided stent). FIGS. 5A-5C illustrate how the tubular seal 130 can be secured to the expandable member 110, e.g., a braided stent, by a plurality of cross stitches connecting the tubular seal 130 to a pair of overlapping wire members of the braided stent. As shown in FIGS. 1A-1C and 5A-5C, expandable member 110 can be a braided stent including one or more wires having a first set of segments 114 extending helically in a first direction and a second set of segments 116 extending helically in a second direction such that the first set of segments 114 cross the second set of segments 116 at intersection points 118. As shown, one or more wires can have inflow crowns 115 at an end of the braided stent where the wires transition from first segments 114 to second segments 116. In some cases, cross stitches 132 secure tubular seal 130 at an intersection 118 to two crossing segments 114, 116 of the braided stent. A separate circumferential running stitch 134 can be inserted into preformed apertures 133 to secure the adaptive seal to bottom edges 222 of leaflets 200 shown in FIGS. 2A and 2C. Cross-stitches around the intersections 118 can increase the strength of an attachment of tubular seal 130 to the expandable member 110 while also allowing for improved load transfer to the expandable member 110. In some cases, the cross stitches secure tubular seal 130 at intersections 118 located immediately above (proximal) the inflow crowns 115. Cross stitches 132 can be formed by passing two stitches 132 a, 132 b of a suture in orthogonal directions over the intersections 118 and through the tubular seal 130. In some cases, preformed apertures 131 for cross stitch 132 can be formed in the tubular seal 130. In some cases, a portion of the tubular seal 130 that is sutured by cross stitch 132 includes an internal fabric, such as those discussed below. Each cross stitch 132 can be knotted independently. As shown in FIG. 5C, cross stitches 132 each include a separate knot 137. Additionally, cross stitches 132 can be arranged to not pass through leaflets 200. Cross stitches 132 can be repeated at a plurality of intersections 118 (FIG. 5A) circumferentially around an inflow end of a prosthetic heart valve provided herein such that an entire circumference of tubular seal 130 is securely attached. In some cases, each intersection 118 immediately adjacent to inflow crowns 115 is sutured to tubular seal 130 via a cross stitch provided herein. The tubular seal stitching pattern provided herein can increase the strength of the attachment between the tubular seal 130 and the expandable member 110 while also allowing for improved load transfer to the expandable member 110 through the use of the plurality of cross stitches.
  • Referring back to FIGS. 1A-1B, tubular seal 130 of prosthetic heart valve 100 can have various suitable structures, arrangements, or materials that allow tubular seal 130 to be secured to leaflets 200 within prosthetic heart valve 100. Various suitable structures, arrangements, or materials of tubular seal 130 can be used to allow tubular seal 130 to extend around the outside of expandable tubular member 110 to prevent blood leakage around leaflets 200.
  • FIG. 6 shows an exemplary mandrel 600 that can be used to construct a tubular seal. The mandrel 600 includes a taper which results in a tubular seal having a slightly smaller diameter proximal end compared to the diameter of the distal end. In some cases, the diameter of the proximal end can include a diameter reduction of about 3% to about 30% as compared to the diameter of the distal end. The taper allows the tubular seal to be removed from the mandrel with relative ease upon completion of the fabrication process. The smaller proximal diameter of the tubular seal tends to cause the proximal projections to lie more firmly against an anchor element of the replacement heart valve. In some cases, the surface of the mandrel may be textured to create a tubular seal with a reduced contact area. In some cases, the mandrel can be textured using a bead blasting process. In combination with the selection of a relatively hard outer layer, a textured seal surface is believed to result in a lower friction surface.
  • FIG. 7A shows a tubular seal 730 that includes an inflow end region 740 and an outflow end region 750. In some cases, at least a portion of tubular seal 730 can include a polymeric web. In some cases, the polymeric web can be a thin film, a porous layer, a mesh-like or net-like structure, or a porous network, e.g., a polymeric matrix. In some cases, for example, inflow end region 740 of tubular seal 130 can include a polymeric web. In some cases, inflow end region 740 can be a portion of a polymeric web retaining a fabric. In some cases, polymeric web can include an elastic material. In some cases, the polymeric web can include an elastomeric matrix.
  • In some cases, inflow end region 740 can be secured to bottom edges of a plurality of leaflets at an inflow end of a prosthetic heart valve provided herein, e.g., prosthetic heart valve 100, and have outflow end region 750 extend around an outer surface of an expandable member (e.g., a braided stent) to restrict blood flow around the leaflets. In some cases, a fabric can be embedded within the polymeric web such that the polymeric web forms a polymeric matrix around the fabric. In some cases, the polymeric web can include an elastic material. In some cases, an elastic polymeric web can conform to adjacent surfaces of a prosthetic heart valve provided herein to prove a resilient seal. The elastomeric polymer matrix can furthermore conform to the expandable member as the expandable member changed between a restricted configuration and an expanded configuration. In some cases, an elastic material can allow the tubular seal to return to its original length when the expandable member returns to the restricted configuration without tearing.
  • In some cases, at least a portion of the tubular seal 130, such as the polymeric web or matrix, can include one or more layers of an elastomeric polymer. In some cases, tubular seal 130 can include a polycarbonate, polyurethane, silicone, polytetrafluoroethylene (PTFE), or a combination thereof. Other suitable materials include, but are not limited to, natural and synthetic rubbers, including cis-1,4-polyisoprene rubber, styrene/butadiene copolymers, polybutadiene rubber, styrene/isoprene/butadiene rubber, butyl rubber, halobutyl rubber, polyurethane elastomers including elastomers based on both aromatic and aliphatic isocyanates, flexible polyolefins including flexible polyethylene and polypropylene homopolymers and copolymers, styrenic thermoplastic elastomers, polyamide elastomers, polyamide-ether elastomers, ester-ether or ester-ester elastomers, flexible ionomers, thermoplastic vulcanizates, flexible poly(vinyl chloride) homopolymers and copolymers, acrylic polymers, and a combination thereof. In some cases, tubular seal 130 can include an aliphatic polycarbonate-based thermoplastic urethane. In some cases, tubular seal 130 can include an elastomeric polymer having a hardness ranging from 3.07 MPa to 9.9 MPa, or a durometer ranging from 75 Shore A to 75 Shore D using ASTM standard D2240 in force on Jan. 1, 2014. In some cases, tubular seal 130 can include a polymeric material having the mechanical properties shown in Table I below. Notably, all of the listed ASTM standards refers to the standard in force on Jan. 1, 2014.
  • TABLE I
    ASTM
    Standard
    Durometer Range 75 Shore A-75 Shore D D2240
    Available
    Specific Gravity 1.10-1.14 D792
    Melt Flow 2-26 g/10 min(205° C./3.26 kg) D1238
    ASTM
    MECHANICAL PROPERTY RANGES Standard
    Durometer 75A-B20 55D 75D 75D
    Ultimate Tensile  400-9000  5000-10000 3000-8000 D638
    Strength (psi)
    Tensile (psi)
    @50% elongation 350-650 1500-1800 3000-8000 D638
    @100% elongation 550-850 1800-2200 3000-8000 D638
    @200% elongation  600-1200 2800-4200 D638
    @300% elongation 1200-2000  4200-10000 D630
    Ultimate 350-750 200-400 100-300 D638
    Elongation (%)
  • In some cases, referring back to FIGS. 1A and 1B, tubular seal 130 can include attachment structures, e.g., grommets 136, to improve the attachment of the tubular seal 130 to leaflets 200 and/or expandable member 110.
  • In some cases, tubular seal 730 can include a fabric retained by a polymeric web such that the fabric reinforces the polymeric web to allow the tubular seal to be secured to a prosthetic heart valve provided herein. Referring to FIG. 7A, for example, inflow end region 740 of tubular seal 730 can include a fabric embedded within an elastomeric material. Also shown in FIG. 7A, outflow end region 750 of tubular seal 730 can include a plurality of grommets 732. The fabric of inflow end region 740 can be a woven material. In some cases, the fabric can have warp threads and/or weft threads. In some cases, the fabric can be composed of fibers having an average thread diameter from about 0.5 microns to about 50 microns (or from about 0.00002 inches to about 0.002 inches), more preferably from about 20 micron to about 40 microns (or about 0.0008 inches to about 0.002 inches). More preferably, in some cases, the fabric is composed of fibers having a thread diameter of about 27 microns (or about 0.0011 inches).
  • In some cases, the fabric can include non-elastomeric fibers, or non-elastic fibers. Suitable non-elastomeric fiber materials include, but are not limited to, polyolefins, polyesters such as PES 38/31 manufactured by SaatiTech, and polyamides. More particularly, the polyolefins can include, for example, polyethylenes, polypropylenes, polybutenes, ethylene copolymers, propylene copolymers, butene copolymers, and combinations thereof. Because the fabric can include non-elastic fibers, inflow end region 740 and outflow end region 750 can have different overall elastic properties.
  • As shown in FIG. 7A, the fabric of a tubular seal has a non-linear edge defining an interface 753 between inflow end region 740 and the outflow end region 750. In some cases, interface 753 between the inflow end region 740 and the outflow end region 750 can be non-linear due to a non-linear edge of the fabric within inflow end region 740. As shown in FIG. 7A, the non-linear edge can be sinusoidal 753. In some cases, as shown in FIGS. 7C-7F, the non-linear edge can be a zigzagged edge 754, a stepped edge 755, or a scalloped edge 756,772, 782.
  • FIGS. 7E and 7F provide alternative embodiments of tubular seals 770, 780 having scalloped, non-linear edges. As shown, the scalloped, non-linear edges define non-linear circumferential interfaces 772, 782 between an inflow end region 774, 784 and an outflow end region 776, 786. Interfaces 772, 782, as shown in FIGS. 7E and 7F, have a scalloped shape defined by a major radius Ra, a minor radius Ri, a wavelength (λ) and a transition zone length (l). In some cases, major radius Ra can be the radius proximate the inflow end region and minor radius Ri can be the radius proximate the outflow end region. In some cases, major radius Ra can be the radius proximate the outflow end region and minor radius Ri can be the radius proximate the inflow end region. As shown in FIGS. 7E and 7F, major radius Ra is larger than the minor Ri. In some cases, major and minor radii Ra, Ri are equal and form a sinusoidal-shaped interface. In some cases, the ratio between major radius Ra and minor radius Ri can range from 1:1 to 2:1, 2:1 to 3:1, from 3:1 to 4:1, or from 4:1 to 5:1. In some cases, a necked region 790 (see FIG. 7F) can be formed between minor radius Ri and major radius Ra. In some cases, minor radius Ri can form bulbous ends, as shown in FIG. 7F, to increase the interface length and improve durability of tubular seal 780 at or near interface 782. The interfaces described herein provide the benefit of preventing or minimizing tear propagation in the tubular seal while providing sufficient bond strength to maintain the bond between the inflow and outflow end regions of the tubular seal. In some cases, the interfaces described herein can prevent or minimize a tear from propagating further at the interface region by redirecting the tear or by providing a barrier to the tear.
  • In some cases, the major radius Ra and/or the minor radius Ri can range from about 1.3 millimeters to about 2.54 millimeters (or about 0.050 inches to about 0.100 inches), from about 1.8 millimeters to about 2.0 millimeters (or about 0.070 inches to about 0.080 inches), from about 2.0 millimeters to about 2.54 millimeters (or about 0.080 inches to about 0.100 inches), or from about 2.3 millimeters to about 2.4 millimeters (or about 0.090 to about 0.095 inches). In some cases, the major radius Ra and/or the minor radius Ri can range from about 0.51 millimeters to about 0.76 millimeters (or about 0.020 inches to about 0.030 inches), from about 0.76 millimeters to about 1.0 millimeters (or about 0.030 inches to about 0.040 inches), from about 1.0 millimeters to about 1.3 millimeters (or about 0.040 inches to about 0.050 inches), from about 0.51 millimeters to about 1.0 millimeters (about 0.020 inches to about 0.040 inches), or from about 0.51 millimeters to about 1.3 millimeters (or about 0.020 inches to about 0.050 inches). In some cases, the wavelength (λ) of the scalloped-shaped interface, or the length of one repeating scallop shape, can range from about 2.5 millimeters to about 1.0 millimeters (or about 0.10 inches to about 0.40 inches), from about 3.8 millimeters to about 5.1 millimeters (or about 0.15 inches to about 0.20 inches), or from about 5.1 millimeters to about 6.35 millimeters (or about 0.20 inches to about 0.25 inches). There can be various suitable lengths of the transition zone length described herein. The transition zone length can be measured as a distance between the crest of the minor radius Ri and the trough of the major radius Ra. In some cases, the transition zone length can range from about 2.8 millimeters to about 3.0 millimeters (or about 0.110 inches to about 0.120 inches), from about 3.0 millimeters to about 3.3 millimeters (or about 0.120 inches to about 0.130 inches), from about 3.3 millimeters to about 3.6 millimeters (or about 0.130 inches to about 0.140 inches), from about 3.6 millimeters to about 3.8 millimeters (or about 0.140 inches to about 0.150 inches), from about 3.8 millimeters to about 4.1 millimeters (or about 0.150 inches to about 0.160 inches), or from about 2.8 millimeters to about 4.1 millimeters (or about 0.110 inches to about 0.160 inches).
  • Referring back to FIG. 7A, in some cases, inflow end region 740 can be thicker than outflow end region 750 because of the presence of a fabric within inflow end region 740. In some cases, inflow end region 740 can have a thickness of about 70 microns (0.0028 inches). In some cases, outflow end region 750 can have a thickness of about 50 microns (about 0.0020 inches). Other suitable thicknesses for inflow end region 740 include thicknesses ranging from about 50 microns to about 90 microns (about 0.0020 inches to about 0.0035 inches), or more preferably, from about 60 microns to about 80 microns (about 0.0025 inches to about 0.0031 inches). Suitable thicknesses for outflow end region 750 include thicknesses ranging from about 30 microns to about 70 microns (about 0.0011 inches to about 0.0028 inches), or more preferably, from about 40 microns to about 60 microns (about 0.0016 inches to about 0.0023 inches). In some cases, suitable thickness ratios of inflow end region 740 relative to outflow end region 750 can range from 1:1 to 1.2:1, from 1.2:1 to 1.4:1, from 1.4:1 to 1.5:1, and from 1.5:1 to 2:1. A non-linear edge can providing a non-linear interface, e.g., interface 753, between inflow end region 740 and outflow end region 750. A prosthetic heart valve that has non-linear interface 753 may have an increased overall diameter that tapers more gradually than a prosthetic heart valve that has a linear interface. The non-linear edge of the fabric can gradually transition the change in elastic properties between the outflow end region 750 and inflow end region 740, mitigating the formation of stress concentrators along an interface that can cause tearing in the tubular member. Additionally, the non-linear shape of interface 753 can minimize or prevent the propagation of tears.
  • Still referring to FIG. 7A, in some cases, the fabric can be arranged in inflow end region 740 to allow for the fabric within inflow end region 740 to stretch in axial and/or radial directions to allow tubular seal 730 to stretch along with an expandable member during implantation. When the fabric does not allow a tubular seal to adequately stretch, the seal can cause non-uniform crimping during manufacturing or damage the expandable member during device deployment. In some cases, a woven fabric can be arranged to have the warp and the waft extend in directions oblique to the axis of tubular seal 730. This can allow the fabric to flex in radial and/or axial directions relative to the axis of tubular seal 730, but limit the fabric from stretching in a direction oblique to the axis. In some cases, both the warp and the waft can extend at an angle between 30 degrees and 60 degrees with the axis of tubular seal 730. In some cases, both the warp and the waft can extend at an angle between 5 degrees and 70 degrees with the axis of tubular seal 730. In some cases, the warp and waft can be arranged within the tubular member 730 to form an angle of about 45 degrees with the axis of tubular seal 730. In some cases, the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions. Limiting the fabric within inflow end region 740 from stretching in a direction oblique to the axis can prevent the fabric from bunching and minimize non-uniform crimping during manufacturing.
  • Additional exemplary tubular seals including a fabric and grommets are described in U.S. Patent Application No. 2013/0090729, which is hereby incorporated by reference in its entirety. For example, U.S. Pat. No. 8,778,020 describes a seal that includes a multilayer, cylindrical seal body having projections alternating with recesses along the proximal edge of the seal body with proximal reinforcing grommets and a distal reinforcing band, which may be formed from a woven or nonwoven fabric and either incorporated within the interior of the multilayer seal body or adhered to the surface thereof.
  • In some cases, tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include a fabric arrangement that allows a seal to stretch in axial and/or radial directions. In some cases, elastomeric materials provided herein can be incorporated into the tubular seals disclosed in U.S. Patent Application No. 2013/0090729. In some cases, the tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include the non-linear interface 753 provided herein.
  • Still referring to FIG. 7A, tubular seal 730 can be created by producing one or more layers of elastomeric polymer, applying the fabric and grommets 732 to the one or more layers of elastomeric polymer, and overcoating the fabric and grommets 732 with one or more additional layers of elastomeric material. In some cases, different layers can have different elastomeric properties. In some cases, tubular seals (e.g., 130, 730, or 760) can include a radially innermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; a radially outermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; and at least one inner layer disposed between the radially outermost layer and a radially innermost layer. In some cases, the modulus of elasticity of the innermost layer is less than the modulus of elasticity of the radially innermost outer layer and the modulus of elasticity of the radially outermost outer layer. In some cases, the elongation to break of the inner layer is greater than the elongation to break of the radially innermost outer layer and the elongation to break of the radially outermost outer layer. Although the radially innermost outer layer and the radially outermost outer layer have been depicted as including the same material, it will be appreciated that they may be compositionally the same or different.
  • The multilayer tubular seals provided herein (e.g., 130, 730, 760) may be formed in a variety of ways. In some cases, multilayer tubular seals provided herein may be formed by successive applications of a polymer solution to an appropriately shaped mandrel, such as that illustrated in FIG. 6. Following a careful cleaning of the mandrel 600, the mandrel may be mounted to an appropriate holding fixture in a spray booth. A first coating composition including a carrier and at least one polymer may be applied to the mandrel 600 and subsequently dried to form a first coated mandrel. In some cases, the first coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The coating composition may be applied as a single layer or multiple layers to achieve the desired dried coating thickness. The grommets 732 (FIG. 7A) and the fabric may be positioned on the first coated mandrel by inserting locating pins 620 in apertures 610 in the tapered mandrel 600 of FIG. 6 that align with corresponding perforations 30 provided in the grommets 32, 34, 36 and the fabric 40. In FIG. 6, only one pin 620 has been illustrated for clarity. In some instances, it may be desirable to secure the plurality of grommets 732 and the fabric to the mandrel or to an underlying coating layer by applying a drop of a first coating composition, or other adhesive composition, to each item to ensure that it remains properly positioned during subsequent processing. The fabric can be cut to a suitable shape having a non-linear edge using any suitable method. In some cases, the fabric can be die cut. In some cases, the fabric can be cut with a blade. In some cases, the fabric can be cut using a femtosecond laser. In some cases, a femtosecond laser cut fabric mitigates the chances of forming stress concentrators along the edge of the fabric.
  • A second coating composition including a carrier and at least one polymer may be applied to the first coated mandrel, the fabric, and the plurality of grommets. In some cases, the second coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The carrier of the second coating composition may be removed, thereby forming a second coated mandrel. The second coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness. In some cases, the second coating composition may be different from the first coating composition. In some cases, the second coating composition may be composed of the same material as the first coating composition.
  • In some cases, a third coating composition including a carrier and at least one polymer may be applied to the second coated mandrel. In some cases, the third coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The carrier of the third coating composition may be removed thereby forming a tubular seal precursor. The third coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness. In some cases, the third coating composition may be different from the first coating composition. In some cases, the third coating composition may be the same as the first coating composition. In some cases, the third coating composition may be different from the second coating composition. In some cases, the third coating composition may be the same as the second coating composition. Following removal of the carrier from the third coating composition, the tubular seal precursor may be inspected to ensure that it is fully formed and meets dimensional specifications, such as a thickness specification. In some cases, a suitable thickness for the tubular seal precursor can range from about 30 microns to about 75 microns (about 0.001 inches to about 0.0030 inches) or from about 50 microns to about 120 microns (about 0.002 inches to about 0.0047 inches). Other suitable thicknesses for the tubular seal precursor include a range from about 20 microns to about 40 microns (about 0.0008 inches to about 0.002 inches), about 30 microns to about 50 microns (about 0.001 inches to about 0.002 inches), about 50 microns to about 75 microns (about 0.002 inches to about 0.0029 inches), about 50 microns to about 100 microns (about 0.002 inches to about 0.004 inches), about 100 microns to about 120 microns (about 0.004 inches to about 0.0047 inches), about 100 microns to about 150 microns (about 0.004 inches to about 0.0059 inches), about 150 microns to about 200 microns (about 0.0059 inches to about 0.0079 inches), as well as any thickness value within any of the listed ranges.
  • In some cases, the tubular seal precursor may be inspected to ensure that it meets certain functional specifications, e.g., tensile and frictional specifications. The tubular seal precursor may then be trimmed by laser cutting, or blade cutting, to conform to dimensional specifications and removed from the tapered seal-forming mandrel as a formed tubular seal. In some cases, at least some preformed apertures for suturing tubular seal to expandable member 110 and/or leaflets 200 (see FIGS. 1A and 1B) can be performed by laser cutting. In some cases, at least some of the grommets may be formed by a laser cutting operation performed on a tubular seal precursor. In some cases, grommets 732 of FIG. 7A may be added to the multilayer, generally cylindrical seal, in a step not illustrated, as a proximal band. Subsequent laser cutting of the tubular seal precursor would then simultaneously form grommets 732 by removing the portions of the proximal band located between the projections.
  • In some cases, coating compositions may be selected to provide a relatively stiff dried polymer such as a dried polymer having a Shore D hardness of about 55, or a hardness of about 6.21 Megapascals (MPa). In some cases, coating compositions may be selected to provide a relatively elastomeric dried polymer such as a dried polymer having a Shore A hardness of about 80, or a hardness of about 3.45 MPa. In some cases, the first and third dried polymer layers may have a Shore D hardness of 55, or a hardness of 6.21 MPa, and the second layer may have a Shore A hardness of 80, or a hardness of 3.45 MPa.
  • Although in some cases described above, three polymer layers were employed, it will be appreciated that a greater or lesser number of layers may be employed and that each of the three or more layers may include two or more sublayers. In some cases, the plurality of grommets and the fabric can be positioned between the first and second coating layers. In some cases, the plurality of grommets and the fabric can be positioned elsewhere within the tubular seal, e.g., within a layer, or on the radially innermost or radially outermost surface of the tubular seal.
  • As shown in FIG. 7G, a tubular seal 760 can include a woven or non-woven fabric embedded throughout a polymer or metal matrix structure. In some cases, at least one leaflet of the heart valve can be secured to the tubular seal in a portion of the tubular seal including the woven or non-woven fabric to minimize blood leakage between the tubular seal and the leaflets.
  • FIGS. 8A-8C are illustrations of an exemplary tubular seal 800 secured to an exemplary prosthetic heart valve provided herein. Tubular seal 800, as shown in FIGS. 8A-8C, includes a non-linear edge interface 820 between an inflow end region 840 and an outflow end region 750. FIG. 8A shows tubular seal 800 advancing from a distal end of a deployment device provided herein and expanding radially. FIG. 8B provides an illustration of tubular seal 800 in a further radially expanded and deployed state. FIG. 8C provides a close up illustration of non-linear interface 820 of tubular seal 800.
  • Referring to FIGS. 8B and 8C, tubular seal 800 includes a fabric in inflow end region 840 that has a non-linear edge defining a non-linear circumferential interface 820 between inflow end region 840 and outflow end region 850. As shown in FIGS. 8A-8C, the non-linear edge of the fabric forms a scalloped-shaped interface 820. In some cases, the non-linear edge can form a sinusoidal, scalloped, or zigzagged shaped interface. The non-linear interface between inflow end region 840 and outflow end region 850 can disperse stress that forms along the interface during stretching of the tubular seal, limit or redirect tear propagation in outflow end region 850 back towards inflow end region 840, and provide a transition zone where the overall outer diameter of the tubular member transitions between a thinner outflow end region thickness to a thicker inflow end region thickness. Variations in thickness between inflow end region 840 and outflow end region 850 can be due to the presence of the fabric within inflow end region 840. In some cases, a tubular seal having a non-linear interface can exhibit a different tensile failure mode than a tubular seal with a linear interface, because the tear propagation has been limited or redirected at interface 820. Advantages of having non-linear interface 820 thus includes increasing the durability of tubular seal 800 at interface 820.
  • In some cases, prosthetic heart valves provided herein include a tubular seal including a woven fabric within an elastomeric matrix where the woven fabric has a non-linear edge within the elastomeric matrix around the circumference of the tubular seal. In some cases, the matrix structure can be made of elastomeric material. In some cases, tubular seal 800 can be made of the fabric alone.
  • Still referring to FIGS. 8A-8C, non-elastic fibers 860 can be part of a knit fabric used in tubular seals provided herein. In some cases, the fabric is a woven or nonwoven fabric having non-elastic fibers 860 arranged to allow the seal radially expand. The fabric can, for example, include non-elastic fiber 860 arranged to allow a portion of tubular seal 800 to stretch in axial and/or radial directions relative to the axis of the tubular seal 800. In some cases, the woven fabric having non-elastic fiber 860 can be positioned along a front edge of a tubular seal positioned to be secured to an expandable member. In some cases, the non-elastic fiber 860 can be arranged at an of between 5 degrees and 70 degrees relative to a central axis of the tubular seal such that the non-elastic fiber 860 allow for a limited stretching of the tubular seal in an axial direction and/or a radial direction. For example, the non-elastic fiber 860 can be part of a woven fabric having fiber in a warp direction and fibers in a waft direction each oriented at an angle of between 5 degrees and 70 degrees relative to a central axis of the tubular seal. Although the non-elastic fiber 860 do not individually stretch, a woven structure can be stretched in directions non-parallel with the orientation of the fiber 860. In some cases, the non-elastic fiber 860 can be arranged within the tubular member 760 to form an angle of about 45 degrees with the axis of the tubular seal. In some cases, the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions.
  • In some cases, fibers 860 of the fabric can allow for the expandable member to be secured to the leaflets and/or to the expandable member. For example, stitches or sutures can extend around the non-elastic fiber 860 within the matrix to ensure that the stitches or sutures do not cause the tubular seal to tear. Tears in the tubular seal can result in leakage of blood past a prosthetic heart valve, which can result in heart failure.
  • In some cases, the non-elastic fiber 860 within the tubular seal can be dispersed throughout a matrix structure, e.g., an elastomeric polymer matrix. In some cases, a fabric of the non-elastic fiber 860 can be throughout the tubular seal. The fabric within the matrix, e.g., an elastomeric polymer matrix, can be arranged to allow for a limited amount of expansion of the tubular seal in a radial direction and/or an axial direction. As discussed below in further detail, non-elastic fiber 860 dispersed throughout the tubular seal can simplify the production of the tubular seal, allow for sutures to be used to attach any section of the tubular seal to one or more other portions of a prosthetic heart valve provided herein, and provide a substantially uniform thickness. A tubular seal having a uniform thickness can facilitate loading of a prosthetic heart valve provided herein into a delivery sheath because non-uniform sections of a seal can catch on a delivery sheath and potentially tear the tubular seal.
  • In some cases, a tubular seal provided herein can include an inflow end region and an outflow end region with the inflow end region including a fabric of non-elastic fiber 860. The inflow end region can be secured to the bottom edges of leaflets and/or an inflow end of the expandable member by stitches and/or sutures. In some cases, an outflow end region can include grommets for attachment to an outer surface of the expandable member. In some cases, the fabric can be arranged to allow for the inflow end region to be expanded in a radial and/or axial direction, which can mitigate the transition in elasticity at the interface between an inflow end region and the outflow end region. An abrupt transition in elasticity between the inflow end region and the outflow end region can result in a stress concentrator along the interface, which can result in a tear along the interface. By having a fabric oriented in the inflow end region to allow axial and/or radial expansion of the inflow end region can disperse stresses formed along the interface during stretching of the tubular seal.
  • In some cases, the fabric can be made of polymeric materials that include, but are not limited to, polyesters, polyolefins such as polyethylene and polypropylene, polyamides, nylons, and combinations thereof. In some cases, the fabric can have a thickness ranging from about 40 to about 80 microns (about 0.002 inches to about 0.003 inches). In some cases, the fabric can be woven such that spacings between individual fiber 860 create openings in the fabric that together constitutes from about 20% to about 40% of a fabric surface.
  • A tubular seal having a fabric embedded throughout the elastomeric material can simplify the manufacturing process. For example, instead of requiring the use of the mandrel 600 to build up layers of elastomeric polymer and position a fabric in select portions of the tubular seal, tubular seal 800 can be created by coating a continuous tube of fabric including non-elastic fiber 860 with an elastomeric polymer and cutting the tube into individual tubular seals or portions of tubular seals. In some cases, portions of the tubular seal having fabric can be created on a separate mandrel and later bonded to portions of the tubular seal that do not have fabric. In some cases, a tube of fabric can be stretched in an axial direction during the coating of the fabric with the elastomeric polymer to enable the tubular seal to have more stretch in a radial direction than an axial direction.
  • A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.

Claims (1)

What is claimed is:
1. A prosthetic heart valve comprising:
an expandable tubular member;
a plurality of leaflets secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member; and
a tubular seal comprising a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member, wherein the tubular seal comprising an outflow end region and an inflow end region, the inflow end region being a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
US17/351,868 2015-03-13 2021-06-18 Prosthetic Heart Valve Having an Improved Tubular Seal Pending US20210307902A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/351,868 US20210307902A1 (en) 2015-03-13 2021-06-18 Prosthetic Heart Valve Having an Improved Tubular Seal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562133048P 2015-03-13 2015-03-13
US15/059,840 US10080652B2 (en) 2015-03-13 2016-03-03 Prosthetic heart valve having an improved tubular seal
US16/139,256 US11065113B2 (en) 2015-03-13 2018-09-24 Prosthetic heart valve having an improved tubular seal
US17/351,868 US20210307902A1 (en) 2015-03-13 2021-06-18 Prosthetic Heart Valve Having an Improved Tubular Seal

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/139,256 Continuation US11065113B2 (en) 2015-03-13 2018-09-24 Prosthetic heart valve having an improved tubular seal

Publications (1)

Publication Number Publication Date
US20210307902A1 true US20210307902A1 (en) 2021-10-07

Family

ID=56887160

Family Applications (3)

Application Number Title Priority Date Filing Date
US15/059,840 Active 2036-04-27 US10080652B2 (en) 2015-03-13 2016-03-03 Prosthetic heart valve having an improved tubular seal
US16/139,256 Active 2036-07-18 US11065113B2 (en) 2015-03-13 2018-09-24 Prosthetic heart valve having an improved tubular seal
US17/351,868 Pending US20210307902A1 (en) 2015-03-13 2021-06-18 Prosthetic Heart Valve Having an Improved Tubular Seal

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US15/059,840 Active 2036-04-27 US10080652B2 (en) 2015-03-13 2016-03-03 Prosthetic heart valve having an improved tubular seal
US16/139,256 Active 2036-07-18 US11065113B2 (en) 2015-03-13 2018-09-24 Prosthetic heart valve having an improved tubular seal

Country Status (4)

Country Link
US (3) US10080652B2 (en)
EP (1) EP3267945A1 (en)
CN (1) CN107592804B (en)
WO (1) WO2016148942A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148925A1 (en) 2001-04-20 2005-07-07 Dan Rottenberg Device and method for controlling in-vivo pressure
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US9681948B2 (en) 2006-01-23 2017-06-20 V-Wave Ltd. Heart anchor device
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
ES2903231T3 (en) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
WO2010128501A1 (en) 2009-05-04 2010-11-11 V-Wave Ltd. Device and method for regulating pressure in a heart chamber
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
US10076403B1 (en) 2009-05-04 2018-09-18 V-Wave Ltd. Shunt for redistributing atrial blood volume
US20210161637A1 (en) 2009-05-04 2021-06-03 V-Wave Ltd. Shunt for redistributing atrial blood volume
JP2013526388A (en) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent
US9629715B2 (en) 2011-07-28 2017-04-25 V-Wave Ltd. Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
CN105555204B (en) * 2013-05-21 2018-07-10 V-波有限责任公司 For delivering the equipment for the device for reducing left atrial pressure
JP6563394B2 (en) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド Radially foldable frame for an artificial valve and method for manufacturing the frame
CA2975361A1 (en) * 2015-02-02 2016-08-11 Symetis Sa Stent seals and method of production
EP4403138A3 (en) 2015-05-01 2024-10-09 JenaValve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
EP3291773A4 (en) 2015-05-07 2019-05-01 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Temporary interatrial shunts
CN109475419B (en) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US10813749B2 (en) * 2016-12-20 2020-10-27 Edwards Lifesciences Corporation Docking device made with 3D woven fabric
US10653523B2 (en) 2017-01-19 2020-05-19 4C Medical Technologies, Inc. Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
US10561495B2 (en) 2017-01-24 2020-02-18 4C Medical Technologies, Inc. Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
AU2018228451B2 (en) 2017-03-03 2022-12-08 V-Wave Ltd. Shunt for redistributing atrial blood volume
US12029647B2 (en) 2017-03-07 2024-07-09 4C Medical Technologies, Inc. Systems, methods and devices for prosthetic heart valve with single valve leaflet
US10820992B2 (en) 2017-04-05 2020-11-03 Opus Medical Therapies, LLC Transcatheter atrial sealing skirt, anchor, and tether and methods of implantation
US11103351B2 (en) 2017-04-05 2021-08-31 Opus Medical Therapies, LLC Transcatheter atrial sealing skirt and related method
US11123187B2 (en) 2017-04-05 2021-09-21 Opus Medical Therapies, LLC Transcatheter atrial anchors and methods of implantation
US10820991B2 (en) 2017-04-05 2020-11-03 Opus Medical Therapies, LLC Transcatheter atrial sealing skirt, anchor, and tether and methods of implantation
US11337685B2 (en) 2017-04-05 2022-05-24 Opus Medical Therapies, LLC Transcatheter anchoring assembly for a mitral valve, a mitral valve, and related methods
US12036113B2 (en) 2017-06-14 2024-07-16 4C Medical Technologies, Inc. Delivery of heart chamber prosthetic valve implant
CN109452990B (en) 2017-09-04 2023-10-31 杭州启明医疗器械股份有限公司 Peripheral leakage prevention support device with lifting unit fold skirt, processing method, skirt fold method and heart valve
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US10898698B1 (en) 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
WO2019142152A1 (en) 2018-01-20 2019-07-25 V-Wave Ltd. Devices and methods for providing passage between heart chambers
US20210259831A1 (en) * 2018-06-20 2021-08-26 W. L. Gore & Associates, Inc. Support structure for an implantable device with enhanced compressive stiffness region(s)
PL238746B1 (en) 2018-07-24 2021-09-27 American Heart Of Poland Spolka Akcyjna Method of forming prefabricated elements used in production of transcatheter aortic valve implantation systems
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
DE102018126828A1 (en) * 2018-10-26 2020-04-30 Nvt Ag Heart valve prosthesis
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
US11865282B2 (en) 2019-05-20 2024-01-09 V-Wave Ltd. Systems and methods for creating an interatrial shunt
WO2021030431A1 (en) * 2019-08-14 2021-02-18 Boston Scientific Scimed, Inc. Replacement heart valve locking element
WO2021150913A1 (en) 2020-01-22 2021-07-29 Opus Medical Therapies, LLC Transcatheter anchor support, systems and methods of implantation
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
US12053375B2 (en) 2020-03-05 2024-08-06 4C Medical Technologies, Inc. Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation
US11992403B2 (en) 2020-03-06 2024-05-28 4C Medical Technologies, Inc. Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells
US20220087814A1 (en) * 2020-09-24 2022-03-24 Cephea Valve Technologies, Inc. Controlled Expression of Expandable Heart Valve
WO2022072687A1 (en) 2020-10-01 2022-04-07 Opus Medical Therapies, LLC Transcatheter anchor support and methods of implantation
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
AU2023252664A1 (en) 2022-04-14 2024-10-17 V-Wave Ltd. Interatrial shunt with expanded neck region
CN116251238B (en) * 2023-02-28 2023-11-21 上海心纪元医疗科技有限公司 Bionic valve leaflet with three-layer structure and manufacturing method thereof

Family Cites Families (698)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US15192A (en) 1856-06-24 Tubular
US1080652A (en) 1913-05-13 1913-12-09 Arthur E Peters Spring-cover.
US2682057A (en) 1951-07-24 1954-06-29 Harry A Lord Heart valve
US2701559A (en) 1951-08-02 1955-02-08 William A Cooper Apparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera
US2832078A (en) 1956-10-17 1958-04-29 Battelle Memorial Institute Heart valve
US3099016A (en) 1960-08-11 1963-07-30 Edwards Miles Lowell Heart valve
US3130418A (en) 1960-11-25 1964-04-28 Louis R Head Artificial heart valve and method for making same
US3113586A (en) 1962-09-17 1963-12-10 Physio Control Company Inc Artificial heart valve
US3143742A (en) 1963-03-19 1964-08-11 Surgitool Inc Prosthetic sutureless heart valve
US3367364A (en) 1964-10-19 1968-02-06 Univ Minnesota Prosthetic heart valve
US3334629A (en) 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
GB1127325A (en) 1965-08-23 1968-09-18 Henry Berry Improved instrument for inserting artificial heart valves
US3587115A (en) 1966-05-04 1971-06-28 Donald P Shiley Prosthetic sutureless heart valves and implant tools therefor
US3445916A (en) 1967-04-19 1969-05-27 Rudolf R Schulte Method for making an anatomical check valve
US3548417A (en) 1967-09-05 1970-12-22 Ronnie G Kischer Heart valve having a flexible wall which rotates between open and closed positions
US3540431A (en) 1968-04-04 1970-11-17 Kazi Mobin Uddin Collapsible filter for fluid flowing in closed passageway
US3570014A (en) 1968-09-16 1971-03-16 Warren D Hancock Stent for heart valve
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3628535A (en) 1969-11-12 1971-12-21 Nibot Corp Surgical instrument for implanting a prosthetic heart valve or the like
US3592184A (en) 1969-12-16 1971-07-13 David H Watkins Heart assist method and catheter
US3642004A (en) 1970-01-05 1972-02-15 Life Support Equipment Corp Urethral valve
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US3755823A (en) 1971-04-23 1973-09-04 Hancock Laboratories Inc Flexible stent for heart valve
US3868956A (en) 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3839741A (en) 1972-11-17 1974-10-08 J Haller Heart valve and retaining means therefor
US3795246A (en) 1973-01-26 1974-03-05 Bard Inc C R Venocclusion device
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4291420A (en) 1973-11-09 1981-09-29 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Artificial heart valve
US3997923A (en) 1975-04-28 1976-12-21 St. Jude Medical, Inc. Heart valve prosthesis and suturing assembly and method of implanting a heart valve prosthesis in a heart
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
CA1069652A (en) 1976-01-09 1980-01-15 Alain F. Carpentier Supported bioprosthetic heart valve with compliant orifice ring
US4056854A (en) 1976-09-28 1977-11-08 The United States Of America As Represented By The Department Of Health, Education And Welfare Aortic heart valve catheter
US5876419A (en) 1976-10-02 1999-03-02 Navius Corporation Stent and method for making a stent
US4297749A (en) 1977-04-25 1981-11-03 Albany International Corp. Heart valve prosthesis
US4233690A (en) 1978-05-19 1980-11-18 Carbomedics, Inc. Prosthetic device couplings
US4222126A (en) 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US4265694A (en) 1978-12-14 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making unitized three leaflet heart valve
US4574803A (en) 1979-01-19 1986-03-11 Karl Storz Tissue cutter
GB2056023B (en) 1979-08-06 1983-08-10 Ross D N Bodnar E Stent for a cardiac valve
US4373216A (en) 1980-10-27 1983-02-15 Hemex, Inc. Heart valves having edge-guided occluders
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
US4326306A (en) 1980-12-16 1982-04-27 Lynell Medical Technology, Inc. Intraocular lens and manipulating tool therefor
US4339831A (en) 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US4470157A (en) 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4323358A (en) 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation
US4345340A (en) 1981-05-07 1982-08-24 Vascor, Inc. Stent for mitral/tricuspid heart valve
US4501030A (en) 1981-08-17 1985-02-26 American Hospital Supply Corporation Method of leaflet attachment for prosthetic heart valves
US4865600A (en) 1981-08-25 1989-09-12 Baxter International Inc. Mitral valve holder
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4406022A (en) 1981-11-16 1983-09-27 Kathryn Roy Prosthetic valve means for cardiovascular surgery
US4423809A (en) 1982-02-05 1984-01-03 Staar Surgical Company, Inc. Packaging system for intraocular lens structures
FR2523810B1 (en) 1982-03-23 1988-11-25 Carpentier Alain ORGANIC GRAFT FABRIC AND PROCESS FOR ITS PREPARATION
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4484579A (en) 1982-07-19 1984-11-27 University Of Pittsburgh Commissurotomy catheter apparatus and method
IT1212547B (en) 1982-08-09 1989-11-30 Iorio Domenico INSTRUMENT FOR SURGICAL USE INTENDED TO MAKE INTERVENTIONS FOR THE IMPLANTATION OF BIOPROTESIS IN HUMAN ORGANS EASIER AND SAFER
DE3230858C2 (en) 1982-08-19 1985-01-24 Ahmadi, Ali, Dr. med., 7809 Denzlingen Ring prosthesis
US4885005A (en) 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US5215541A (en) 1982-11-12 1993-06-01 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US4680031A (en) 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
GB8300636D0 (en) 1983-01-11 1983-02-09 Black M M Heart valve replacements
US4535483A (en) 1983-01-17 1985-08-20 Hemex, Inc. Suture rings for heart valves
US4834755A (en) 1983-04-04 1989-05-30 Pfizer Hospital Products Group, Inc. Triaxially-braided fabric prosthesis
US4610688A (en) 1983-04-04 1986-09-09 Pfizer Hospital Products Group, Inc. Triaxially-braided fabric prosthesis
AR229309A1 (en) 1983-04-20 1983-07-15 Barone Hector Daniel MOUNT FOR CARDIAC VALVES
US4612011A (en) 1983-07-22 1986-09-16 Hans Kautzky Central occluder semi-biological heart valve
US4531943A (en) 1983-08-08 1985-07-30 Angiomedics Corporation Catheter with soft deformable tip
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4585705A (en) 1983-11-09 1986-04-29 Dow Corning Corporation Hard organopolysiloxane release coating
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US5693083A (en) 1983-12-09 1997-12-02 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
US4627436A (en) 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4592340A (en) 1984-05-02 1986-06-03 Boyles Paul W Artificial catheter means
US5007896A (en) 1988-12-19 1991-04-16 Surgical Systems & Instruments, Inc. Rotary-catheter for atherectomy
US4979939A (en) 1984-05-14 1990-12-25 Surgical Systems & Instruments, Inc. Atherectomy system with a guide wire
US4883458A (en) 1987-02-24 1989-11-28 Surgical Systems & Instruments, Inc. Atherectomy system and method of using the same
DE3426300A1 (en) 1984-07-17 1986-01-30 Doguhan Dr.med. 6000 Frankfurt Baykut TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
DE3442088A1 (en) 1984-11-17 1986-05-28 Beiersdorf Ag, 2000 Hamburg HEART VALVE PROSTHESIS
SU1271508A1 (en) 1984-11-29 1986-11-23 Горьковский государственный медицинский институт им.С.М.Кирова Artificial heart valve
US4759758A (en) 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
US4738666A (en) 1985-06-11 1988-04-19 Genus Catheter Technologies, Inc. Variable diameter catheter
US4662885A (en) 1985-09-03 1987-05-05 Becton, Dickinson And Company Percutaneously deliverable intravascular filter prosthesis
GB2181057B (en) 1985-10-23 1989-09-27 Blagoveshchensk G Med Inst Prosthetic valve holder
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
SU1371700A1 (en) 1986-02-21 1988-02-07 МВТУ им.Н.Э.Баумана Prosthesis of heart valve
CH672247A5 (en) 1986-03-06 1989-11-15 Mo Vysshee Tekhnicheskoe Uchil
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4777951A (en) 1986-09-19 1988-10-18 Mansfield Scientific, Inc. Procedure and catheter instrument for treating patients for aortic stenosis
IL83966A (en) 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
AU613886B2 (en) 1986-11-29 1991-08-15 Terumo Kabushiki Kaisha Catheter equipped with balloon
US4878495A (en) 1987-05-15 1989-11-07 Joseph Grayzel Valvuloplasty device with satellite expansion means
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
US4796629A (en) 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4829990A (en) 1987-06-25 1989-05-16 Thueroff Joachim Implantable hydraulic penile erector
JPH088933B2 (en) 1987-07-10 1996-01-31 日本ゼオン株式会社 Catheter
US4851001A (en) 1987-09-17 1989-07-25 Taheri Syde A Prosthetic valve for a blood vein and an associated method of implantation of the valve
US5159937A (en) 1987-09-30 1992-11-03 Advanced Cardiovascular Systems, Inc. Steerable dilatation catheter
US4755181A (en) 1987-10-08 1988-07-05 Matrix Medica, Inc. Anti-suture looping device for prosthetic heart valves
US4819751A (en) 1987-10-16 1989-04-11 Baxter Travenol Laboratories, Inc. Valvuloplasty catheter and method
US4873978A (en) 1987-12-04 1989-10-17 Robert Ginsburg Device and method for emboli retrieval
JPH01290639A (en) 1988-05-17 1989-11-22 Daikin Ind Ltd Production of 1,1,1-trifluoro-2,2-dichloroethane
US4909252A (en) 1988-05-26 1990-03-20 The Regents Of The Univ. Of California Perfusion balloon catheter
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US4917102A (en) 1988-09-14 1990-04-17 Advanced Cardiovascular Systems, Inc. Guidewire assembly with steerable adjustable tip
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
DE8815082U1 (en) 1988-11-29 1989-05-18 Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin Heart valve prosthesis
US4927426A (en) 1989-01-03 1990-05-22 Dretler Stephen P Catheter device
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4966604A (en) 1989-01-23 1990-10-30 Interventional Technologies Inc. Expandable atherectomy cutter with flexibly bowed blades
US4994077A (en) 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
CA2054728C (en) 1989-05-31 2003-07-29 Rodolfo C. Quijano Biological valvular prosthesis
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5047041A (en) 1989-08-22 1991-09-10 Samuels Peter B Surgical apparatus for the excision of vein valves in situ
US4986830A (en) 1989-09-22 1991-01-22 Schneider (U.S.A.) Inc. Valvuloplasty catheter with balloon which remains stable during inflation
US5089015A (en) 1989-11-28 1992-02-18 Promedica International Method for implanting unstented xenografts and allografts
US5002559A (en) 1989-11-30 1991-03-26 Numed PTCA catheter
US5591185A (en) 1989-12-14 1997-01-07 Corneal Contouring Development L.L.C. Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping
US5141494A (en) 1990-02-15 1992-08-25 Danforth Biomedical, Inc. Variable wire diameter angioplasty dilatation balloon catheter
US5238004A (en) 1990-04-10 1993-08-24 Boston Scientific Corporation High elongation linear elastic guidewire
US5037434A (en) 1990-04-11 1991-08-06 Carbomedics, Inc. Bioprosthetic heart valve with elastic commissures
DK124690D0 (en) 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5085635A (en) 1990-05-18 1992-02-04 Cragg Andrew H Valved-tip angiographic catheter
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5197979A (en) 1990-09-07 1993-03-30 Baxter International Inc. Stentless heart valve and holder
US5161547A (en) 1990-11-28 1992-11-10 Numed, Inc. Method of forming an intravascular radially expandable stent
US5217483A (en) 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
US6165292A (en) 1990-12-18 2000-12-26 Advanced Cardiovascular Systems, Inc. Superelastic guiding member
US5152771A (en) 1990-12-31 1992-10-06 The Board Of Supervisors Of Louisiana State University Valve cutter for arterial by-pass surgery
US5282847A (en) 1991-02-28 1994-02-01 Medtronic, Inc. Prosthetic vascular grafts with a pleated structure
DE69222933T2 (en) 1991-03-01 1998-04-02 Applied Med Resources CHOLANGIOGRAPHY CATHETER
JPH05184611A (en) 1991-03-19 1993-07-27 Kenji Kusuhara Valvular annulation retaining member and its attaching method
US5295958A (en) 1991-04-04 1994-03-22 Shturman Cardiology Systems, Inc. Method and apparatus for in vivo heart valve decalcification
US5167628A (en) 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5350398A (en) 1991-05-13 1994-09-27 Dusan Pavcnik Self-expanding filter for percutaneous insertion
US5397351A (en) 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
IT1245750B (en) 1991-05-24 1994-10-14 Sorin Biomedica Emodialisi S R CARDIAC VALVE PROSTHESIS, PARTICULARLY FOR REPLACING THE AORTIC VALVE
US5209741A (en) 1991-07-08 1993-05-11 Endomedix Corporation Surgical access device having variable post-insertion cross-sectional geometry
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US6866650B2 (en) 1991-07-16 2005-03-15 Heartport, Inc. System for cardiac procedures
US5571215A (en) 1993-02-22 1996-11-05 Heartport, Inc. Devices and methods for intracardiac procedures
US5769812A (en) 1991-07-16 1998-06-23 Heartport, Inc. System for cardiac procedures
CA2117088A1 (en) 1991-09-05 1993-03-18 David R. Holmes Flexible tubular device for use in medical applications
US5258042A (en) 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5756476A (en) 1992-01-14 1998-05-26 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell proliferation using antisense oligonucleotides
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
EP0552579B1 (en) 1992-01-22 1996-01-03 Guy-Henri Muller Prosthetic implants for plastic surgery
US5489297A (en) 1992-01-27 1996-02-06 Duran; Carlos M. G. Bioprosthetic heart valve with absorbable stent
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5258023A (en) 1992-02-12 1993-11-02 Reger Medical Development, Inc. Prosthetic heart valve
AU678350B2 (en) 1992-05-08 1997-05-29 Schneider (Usa) Inc. Esophageal stent and delivery tool
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5409019A (en) 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
JP2935751B2 (en) 1993-01-14 1999-08-16 ミードックス メディカルズ インコーポレイテッド Radially expandable tubular prosthesis
US5713951A (en) 1993-02-22 1998-02-03 Heartport, Inc. Thoracoscopic valve prosthesis delivery device
US5431676A (en) 1993-03-05 1995-07-11 Innerdyne Medical, Inc. Trocar system having expandable port
US5772609A (en) 1993-05-11 1998-06-30 Target Therapeutics, Inc. Guidewire with variable flexibility due to polymeric coatings
US5480423A (en) 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
GB9312666D0 (en) 1993-06-18 1993-08-04 Vesely Ivan Bioprostetic heart valve
US5415633A (en) 1993-07-28 1995-05-16 Active Control Experts, Inc. Remotely steered catheterization device
US5443495A (en) 1993-09-17 1995-08-22 Scimed Lifesystems Inc. Polymerization angioplasty balloon implant device
KR970004845Y1 (en) 1993-09-27 1997-05-21 주식회사 수호메디테크 Stent for expanding a lumen
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5389106A (en) 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5713950A (en) 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
EP0657147B1 (en) 1993-11-04 1999-08-04 C.R. Bard, Inc. Non-migrating vascular prosthesis
RU2089131C1 (en) 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
US5476506A (en) 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5443477A (en) 1994-02-10 1995-08-22 Stentco, Inc. Apparatus and method for deployment of radially expandable stents by a mechanical linkage
US5549663A (en) 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
US5556413A (en) 1994-03-11 1996-09-17 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US5476510A (en) 1994-04-21 1995-12-19 Medtronic, Inc. Holder for heart valve
DE4415359C2 (en) 1994-05-02 1997-10-23 Aesculap Ag Surgical tubular shaft instrument
US6139510A (en) 1994-05-11 2000-10-31 Target Therapeutics Inc. Super elastic alloy guidewire
US5765418A (en) 1994-05-16 1998-06-16 Medtronic, Inc. Method for making an implantable medical device from a refractory metal
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5728068A (en) 1994-06-14 1998-03-17 Cordis Corporation Multi-purpose balloon catheter
ES2340142T3 (en) 1994-07-08 2010-05-31 Ev3 Inc. SYSTEM TO CARRY OUT AN INTRAVASCULAR PROCEDURE.
DE4424242A1 (en) 1994-07-09 1996-01-11 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
US5545133A (en) 1994-09-16 1996-08-13 Scimed Life Systems, Inc. Balloon catheter with improved pressure source
TR199501643A2 (en) 1994-12-21 1996-07-21 Nova Nordisk As Method for the treatment of wool with enzymes.
US5674277A (en) 1994-12-23 1997-10-07 Willy Rusch Ag Stent for placement in a body tube
BE1009085A3 (en) 1995-02-10 1996-11-05 De Fays Robert Dr Intra-aortic prosthesis and surgical instruments for the introduction, implementation and fixing in the aortic prosthesis.
US5575818A (en) 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
EP0810845A2 (en) 1995-02-22 1997-12-10 Menlo Care Inc. Covered expanding mesh stent
DE69626105T2 (en) 1995-03-30 2003-10-23 Heartport, Inc. ENDOVASCULAR CATHETER FOR LEADING FROM THE HEART
WO1996030072A1 (en) 1995-03-30 1996-10-03 Heartport, Inc. System and methods for performing endovascular procedures
US5709713A (en) 1995-03-31 1998-01-20 Cardiovascular Concepts, Inc. Radially expansible vascular prosthesis having reversible and other locking structures
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5824064A (en) 1995-05-05 1998-10-20 Taheri; Syde A. Technique for aortic valve replacement with simultaneous aortic arch graft insertion and apparatus therefor
US5534007A (en) 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5571175A (en) 1995-06-07 1996-11-05 St. Jude Medical, Inc. Suture guard for prosthetic heart valve
US5728152A (en) 1995-06-07 1998-03-17 St. Jude Medical, Inc. Bioresorbable heart valve support
US5716417A (en) 1995-06-07 1998-02-10 St. Jude Medical, Inc. Integral supporting structure for bioprosthetic heart valve
DE19532846A1 (en) 1995-09-06 1997-03-13 Georg Dr Berg Valve for use in heart
US5807405A (en) 1995-09-11 1998-09-15 St. Jude Medical, Inc. Apparatus for attachment of heart valve holder to heart valve prosthesis
US5735842A (en) 1995-09-11 1998-04-07 St. Jude Medical, Inc. Low profile manipulators for heart valve prostheses
US6287336B1 (en) 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
DE19546692C2 (en) 1995-12-14 2002-11-07 Hans-Reiner Figulla Self-expanding heart valve prosthesis for implantation in the human body via a catheter system
US5861028A (en) 1996-09-09 1999-01-19 Shelhigh Inc Natural tissue heart valve and stent prosthesis and method for making the same
US5855602A (en) 1996-09-09 1999-01-05 Shelhigh, Inc. Heart valve prosthesis
ATE290832T1 (en) 1996-01-05 2005-04-15 Medtronic Inc EXPANDABLE ENDOLUMINAL PROSTHESES
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
WO1997027959A1 (en) 1996-01-30 1997-08-07 Medtronic, Inc. Articles for and methods of making stents
JPH09215753A (en) 1996-02-08 1997-08-19 Schneider Usa Inc Self-expanding stent made of titanium alloy
US6402736B1 (en) 1996-02-16 2002-06-11 Joe E. Brown Apparatus and method for filtering intravascular fluids and for delivering diagnostic and therapeutic agents
US5716370A (en) 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US6402780B2 (en) 1996-02-23 2002-06-11 Cardiovascular Technologies, L.L.C. Means and method of replacing a heart valve in a minimally invasive manner
US5695498A (en) 1996-02-28 1997-12-09 Numed, Inc. Stent implantation system
US5720391A (en) 1996-03-29 1998-02-24 St. Jude Medical, Inc. Packaging and holder for heart valve prosthesis
US5891191A (en) 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
US5885228A (en) 1996-05-08 1999-03-23 Heartport, Inc. Valve sizer and method of use
WO1997042879A1 (en) 1996-05-14 1997-11-20 Embol-X, Inc. Aortic occluder with associated filter and methods of use during cardiac surgery
DE69719237T2 (en) 1996-05-23 2003-11-27 Samsung Electronics Co., Ltd. Flexible, self-expandable stent and method for its manufacture
US7238197B2 (en) 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
JP4014226B2 (en) 1996-06-20 2007-11-28 ヴァスキュテック リミテッド Repair of the body's path by prosthesis
US5855601A (en) 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5755783A (en) 1996-07-29 1998-05-26 Stobie; Robert Suture rings for rotatable artificial heart valves
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US6702851B1 (en) 1996-09-06 2004-03-09 Joseph A. Chinn Prosthetic heart valve with surface modification
US5800531A (en) 1996-09-30 1998-09-01 Baxter International Inc. Bioprosthetic heart valve implantation device
US6022370A (en) 1996-10-01 2000-02-08 Numed, Inc. Expandable stent
US5749890A (en) 1996-12-03 1998-05-12 Shaknovich; Alexander Method and system for stent placement in ostial lesions
NL1004827C2 (en) 1996-12-18 1998-06-19 Surgical Innovations Vof Device for regulating blood circulation.
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
GB9701479D0 (en) 1997-01-24 1997-03-12 Aortech Europ Ltd Heart valve
US6241757B1 (en) 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
CA2281519A1 (en) 1997-02-19 1998-08-27 Condado Medical Devices Corporation Multi-purpose catheters, catheter systems, and radiation treatment
US6152946A (en) 1998-03-05 2000-11-28 Scimed Life Systems, Inc. Distal protection device and method
US5830229A (en) 1997-03-07 1998-11-03 Micro Therapeutics Inc. Hoop stent
US6416510B1 (en) 1997-03-13 2002-07-09 Biocardia, Inc. Drug delivery catheters that attach to tissue and methods for their use
US5817126A (en) 1997-03-17 1998-10-06 Surface Genesis, Inc. Compound stent
US5824053A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5824055A (en) 1997-03-25 1998-10-20 Endotex Interventional Systems, Inc. Stent graft delivery system and methods of use
US5928281A (en) 1997-03-27 1999-07-27 Baxter International Inc. Tissue heart valves
US5868783A (en) 1997-04-16 1999-02-09 Numed, Inc. Intravascular stent with limited axial shrinkage
US5860966A (en) 1997-04-16 1999-01-19 Numed, Inc. Method of securing a stent on a balloon catheter
JP4083241B2 (en) 1997-04-23 2008-04-30 アーテミス・メディカル・インコーポレイテッド Bifurcated stent and distal protection system
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6206917B1 (en) 1997-05-02 2001-03-27 St. Jude Medical, Inc. Differential treatment of prosthetic devices
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5911734A (en) 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6676682B1 (en) 1997-05-08 2004-01-13 Scimed Life Systems, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6258120B1 (en) 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
JP3645399B2 (en) 1997-06-09 2005-05-11 住友金属工業株式会社 Endovascular stent
AU8337898A (en) 1997-06-17 1999-01-04 Sante Camilli Implantable valve for blood vessels
US5861024A (en) 1997-06-20 1999-01-19 Cardiac Assist Devices, Inc Electrophysiology catheter and remote actuator therefor
US5906619A (en) 1997-07-24 1999-05-25 Medtronic, Inc. Disposable delivery device for endoluminal prostheses
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US5984957A (en) 1997-08-12 1999-11-16 Schneider (Usa) Inc Radially expanded prostheses with axial diameter control
US5954766A (en) 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US6056722A (en) 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
US5984959A (en) 1997-09-19 1999-11-16 United States Surgical Heart valve replacement tools and procedures
US5925063A (en) 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US6071308A (en) 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
ATE452598T1 (en) 1997-11-07 2010-01-15 Salviac Ltd EMBOLIC PROTECTION DEVICE
AU1675199A (en) 1997-12-15 1999-07-05 Domnick Hunter Limited Filter assembly
US6695864B2 (en) 1997-12-15 2004-02-24 Cardeon Corporation Method and apparatus for cerebral embolic protection
US6165209A (en) 1997-12-15 2000-12-26 Prolifix Medical, Inc. Vascular stent for reduction of restenosis
CA2315211A1 (en) 1997-12-29 1999-07-08 The Cleveland Clinic Foundation System for minimally invasive insertion of a bioprosthetic heart valve
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US6096074A (en) 1998-01-27 2000-08-01 United States Surgical Stapling apparatus and method for heart valve replacement
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
JP2003522550A (en) 1998-02-10 2003-07-29 アーテミス・メディカル・インコーポレイテッド Occlusion, fixation, tensioning, and diverting devices and methods of use
WO1999039648A1 (en) 1998-02-10 1999-08-12 Dubrul William R Entrapping apparatus and method for use
EP0935978A1 (en) 1998-02-16 1999-08-18 Medicorp S.A. Angioplasty and stent delivery catheter
US6623521B2 (en) 1998-02-17 2003-09-23 Md3, Inc. Expandable stent with sliding and locking radial elements
US6280467B1 (en) 1998-02-26 2001-08-28 World Medical Manufacturing Corporation Delivery system for deployment and endovascular assembly of a multi-stage stented graft
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US7491232B2 (en) 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6776791B1 (en) 1998-04-01 2004-08-17 Endovascular Technologies, Inc. Stent and method and device for packing of same
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US6450989B2 (en) 1998-04-27 2002-09-17 Artemis Medical, Inc. Dilating and support apparatus with disease inhibitors and methods for use
US6319241B1 (en) 1998-04-30 2001-11-20 Medtronic, Inc. Techniques for positioning therapy delivery elements within a spinal cord or a brain
US6059827A (en) 1998-05-04 2000-05-09 Axya Medical, Inc. Sutureless cardiac valve prosthesis, and devices and methods for implanting them
JP4583597B2 (en) 1998-05-05 2010-11-17 ボストン サイエンティフィック リミテッド Smooth end stent
US6352554B2 (en) 1998-05-08 2002-03-05 Sulzer Vascutek Limited Prosthetic tubular aortic conduit and method for manufacturing the same
US6093203A (en) 1998-05-13 2000-07-25 Uflacker; Renan Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
AU754156B2 (en) 1998-06-02 2002-11-07 Cook Incorporated Multiple-sided intraluminal medical device
US6630001B2 (en) 1998-06-24 2003-10-07 International Heart Institute Of Montana Foundation Compliant dehyrated tissue for implantation and process of making the same
AU749930B2 (en) 1998-07-10 2002-07-04 Shin Ishimaru Stent (or stent graft) indwelling device
US6159239A (en) 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6179860B1 (en) 1998-08-19 2001-01-30 Artemis Medical, Inc. Target tissue localization device and method
US6312461B1 (en) 1998-08-21 2001-11-06 John D. Unsworth Shape memory tubular stent
US6358276B1 (en) 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6051014A (en) 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US6475239B1 (en) 1998-10-13 2002-11-05 Sulzer Carbomedics Inc. Method for making polymer heart valves with leaflets having uncut free edges
US6254612B1 (en) 1998-10-22 2001-07-03 Cordis Neurovascular, Inc. Hydraulic stent deployment system
US6146366A (en) 1998-11-03 2000-11-14 Ras Holding Corp Device for the treatment of macular degeneration and other eye disorders
US6508803B1 (en) 1998-11-06 2003-01-21 Furukawa Techno Material Co., Ltd. Niti-type medical guide wire and method of producing the same
US6214036B1 (en) 1998-11-09 2001-04-10 Cordis Corporation Stent which is easily recaptured and repositioned within the body
US6336937B1 (en) 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
DE19857887B4 (en) 1998-12-15 2005-05-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring support for a heart valve prosthesis
US6363938B2 (en) 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
FR2788217A1 (en) 1999-01-12 2000-07-13 Brice Letac PROSTHETIC VALVE IMPLANTABLE BY CATHETERISM, OR SURGICAL
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
DK1154738T3 (en) 1999-01-27 2010-07-26 Medtronic Inc Cardiac arrest devices
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
AU766108C (en) 1999-02-01 2004-07-22 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
EP1576937B1 (en) 1999-02-01 2012-10-31 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delvery of the same
WO2000044309A2 (en) 1999-02-01 2000-08-03 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
DE19904975A1 (en) 1999-02-06 2000-09-14 Impella Cardiotech Ag Device for intravascular heart valve surgery
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20020138094A1 (en) 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
DE19907646A1 (en) 1999-02-23 2000-08-24 Georg Berg Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire.
US6171327B1 (en) 1999-02-24 2001-01-09 Scimed Life Systems, Inc. Intravascular filter and method
US6905743B1 (en) 1999-02-25 2005-06-14 Boston Scientific Scimed, Inc. Dimensionally stable balloons
US6231551B1 (en) 1999-03-01 2001-05-15 Coaxia, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US6743196B2 (en) 1999-03-01 2004-06-01 Coaxia, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
IL128938A0 (en) 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US6673089B1 (en) 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
US6319281B1 (en) 1999-03-22 2001-11-20 Kumar R. Patel Artificial venous valve and sizing catheter
US7226467B2 (en) 1999-04-09 2007-06-05 Evalve, Inc. Fixation device delivery catheter, systems and methods of use
US6309417B1 (en) 1999-05-12 2001-10-30 Paul A. Spence Heart valve and apparatus for replacement thereof
WO2000067661A2 (en) 1999-05-12 2000-11-16 Spence Paul A Heart valve and apparatus for replacement thereof, blood vessel leak detector and temporary pacemaker lead
US6858034B1 (en) 1999-05-20 2005-02-22 Scimed Life Systems, Inc. Stent delivery system for prevention of kinking, and method of loading and using same
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
JP3755862B2 (en) 1999-05-26 2006-03-15 キヤノン株式会社 Synchronized position control apparatus and method
EP1057460A1 (en) 1999-06-01 2000-12-06 Numed, Inc. Replacement valve assembly and method of implanting same
EP1057459A1 (en) 1999-06-01 2000-12-06 Numed, Inc. Radially expandable stent
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
AU6000200A (en) 1999-07-16 2001-02-05 Biocompatibles Limited Braided stent
US6179859B1 (en) 1999-07-16 2001-01-30 Baff Llc Emboli filtration system and methods of use
US6544279B1 (en) 2000-08-09 2003-04-08 Incept, Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US6142987A (en) 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6346116B1 (en) 1999-08-03 2002-02-12 Medtronic Ave, Inc. Distal protection device
US6168579B1 (en) 1999-08-04 2001-01-02 Scimed Life Systems, Inc. Filter flush system and methods of use
US6235044B1 (en) 1999-08-04 2001-05-22 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US6187016B1 (en) 1999-09-14 2001-02-13 Daniel G. Hedges Stent retrieval device
US6829497B2 (en) 1999-09-21 2004-12-07 Jamil Mogul Steerable diagnostic catheters
IT1307268B1 (en) 1999-09-30 2001-10-30 Sorin Biomedica Cardio Spa DEVICE FOR HEART VALVE REPAIR OR REPLACEMENT.
US6371983B1 (en) 1999-10-04 2002-04-16 Ernest Lane Bioprosthetic heart valve
US6364895B1 (en) 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
FR2799364B1 (en) 1999-10-12 2001-11-23 Jacques Seguin MINIMALLY INVASIVE CANCELING DEVICE
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US6352708B1 (en) 1999-10-14 2002-03-05 The International Heart Institute Of Montana Foundation Solution and method for treating autologous tissue for implant operation
WO2001026584A1 (en) 1999-10-14 2001-04-19 United Stenting, Inc. Stents with multilayered struts
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6585758B1 (en) 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
FR2815844B1 (en) 2000-10-31 2003-01-17 Jacques Seguin TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US6849085B2 (en) 1999-11-19 2005-02-01 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US7195641B2 (en) 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6379383B1 (en) 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
BR0107897A (en) 2000-01-27 2002-11-05 3F Therapeutics Inc Prosthetic heart valve without stent, semi-lunar heart valve without stent, process for producing a prosthetic tubular heart valve without stent, process for making a prosthetic heart valve, and, process for producing a prosthetic valve
US6872226B2 (en) 2001-01-29 2005-03-29 3F Therapeutics, Inc. Method of cutting material for use in implantable medical device
PL211544B1 (en) 2000-01-31 2012-05-31 Cook Biotech Inc Heart valve device containing set of valve stent
US6652571B1 (en) 2000-01-31 2003-11-25 Scimed Life Systems, Inc. Braided, branched, implantable device and processes for manufacture thereof
US6622604B1 (en) 2000-01-31 2003-09-23 Scimed Life Systems, Inc. Process for manufacturing a braided bifurcated stent
US6398807B1 (en) 2000-01-31 2002-06-04 Scimed Life Systems, Inc. Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US6821297B2 (en) 2000-02-02 2004-11-23 Robert V. Snyders Artificial heart valve, implantation instrument and method therefor
US20050267560A1 (en) 2000-02-03 2005-12-01 Cook Incorporated Implantable bioabsorbable valve support frame
US6540768B1 (en) 2000-02-09 2003-04-01 Cordis Corporation Vascular filter system
US6344044B1 (en) 2000-02-11 2002-02-05 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
DE10010073B4 (en) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring for implantable heart valve prostheses
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
EP1253871B1 (en) 2000-03-10 2007-02-14 Anthony T. Don Michael Vascular embolism preventon device employing filters
US6695865B2 (en) 2000-03-20 2004-02-24 Advanced Bio Prosthetic Surfaces, Ltd. Embolic protection device
US6468303B1 (en) 2000-03-27 2002-10-22 Aga Medical Corporation Retrievable self expanding shunt
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
GB2369575A (en) 2000-04-20 2002-06-05 Salviac Ltd An embolic protection system
US7686842B2 (en) 2000-05-04 2010-03-30 Oregon Health Sciences University Endovascular stent graft
IL136213A0 (en) 2000-05-17 2001-05-20 Xtent Medical Inc Selectively expandable and releasable stent
US20050043757A1 (en) 2000-06-12 2005-02-24 Michael Arad Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
SE522805C2 (en) 2000-06-22 2004-03-09 Jan Otto Solem Stent Application System
US6527800B1 (en) 2000-06-26 2003-03-04 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US6676698B2 (en) 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
EP1401358B1 (en) 2000-06-30 2016-08-17 Medtronic, Inc. Apparatus for performing a procedure on a cardiac valve
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US6572643B1 (en) 2000-07-19 2003-06-03 Vascular Architects, Inc. Endoprosthesis delivery catheter assembly and method
ES2365208T3 (en) 2000-07-24 2011-09-26 Jeffrey Grayzel CATHETER WITH RIGIDIZED BALLOON FOR DILATATION AND IMPLEMENTATION OF ENDOVASCULAR PROSTHESIS.
US6773454B2 (en) 2000-08-02 2004-08-10 Michael H. Wholey Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
US6485501B1 (en) 2000-08-11 2002-11-26 Cordis Corporation Vascular filter system with guidewire and capture mechanism
US6572652B2 (en) 2000-08-29 2003-06-03 Venpro Corporation Method and devices for decreasing elevated pulmonary venous pressure
US6543610B1 (en) 2000-09-12 2003-04-08 Alok Nigam System for packaging and handling an implant and method of use
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US7381220B2 (en) 2000-09-20 2008-06-03 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US6893459B1 (en) 2000-09-20 2005-05-17 Ample Medical, Inc. Heart valve annulus device and method of using same
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
US6602288B1 (en) 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
DE10049813C1 (en) 2000-10-09 2002-04-18 Universitaetsklinikum Freiburg Instrument for the local removal of built-up matter at an aortic valve, in a human or animal heart, is a hollow catheter with a cutting unit at the far end within a closure cap for minimum invasion
DE10049814B4 (en) 2000-10-09 2006-10-19 Universitätsklinikum Freiburg Device for supporting surgical procedures within a vessel, in particular for minimally invasive explantation and implantation of heart valves
DE10049815B4 (en) 2000-10-09 2005-10-13 Universitätsklinikum Freiburg Device for local ablation of an aortic valve on the human or animal heart
DE10049812B4 (en) 2000-10-09 2004-06-03 Universitätsklinikum Freiburg Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart
EP1326672A4 (en) 2000-10-18 2007-03-07 Nmt Medical Inc Over-the-wire interlock attachment/detachment mechanism
EP1341435A4 (en) 2000-11-07 2005-08-17 Artemis Medical Inc Tissue separator assembly and method
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US6843802B1 (en) 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
CA2436803C (en) 2000-11-21 2009-09-15 Rex Medical, L.P. Percutaneous aortic valve
US6974476B2 (en) 2003-05-05 2005-12-13 Rex Medical, L.P. Percutaneous aortic valve
EP1347794A2 (en) 2000-11-27 2003-10-01 Medtronic, Inc. Stents and methods for preparing stents from wires having hydrogel coating layers thereon
US6953332B1 (en) 2000-11-28 2005-10-11 St. Jude Medical, Inc. Mandrel for use in forming valved prostheses having polymer leaflets by dip coating
US6663588B2 (en) 2000-11-29 2003-12-16 C.R. Bard, Inc. Active counterforce handle for use in bidirectional deflectable tip instruments
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US20040093075A1 (en) 2000-12-15 2004-05-13 Titus Kuehne Stent with valve and method of use thereof
US6471708B2 (en) 2000-12-21 2002-10-29 Bausch & Lomb Incorporated Intraocular lens and additive packaging system
US20020120328A1 (en) 2000-12-21 2002-08-29 Pathak Chandrashekhar Prabhakar Mechanical heart valve packaged in a liquid
US6468660B2 (en) 2000-12-29 2002-10-22 St. Jude Medical, Inc. Biocompatible adhesives
WO2002056955A1 (en) 2001-01-18 2002-07-25 Edwards Lifesciences Corporation Arterial cannula with perforated filter lumen
US6610077B1 (en) 2001-01-23 2003-08-26 Endovascular Technologies, Inc. Expandable emboli filter and thrombectomy device
US6623518B2 (en) 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock
US20020123755A1 (en) 2001-03-01 2002-09-05 Scimed Life Systems, Inc. Embolic protection filter delivery sheath
US6562058B2 (en) 2001-03-02 2003-05-13 Jacques Seguin Intravascular filter system
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
US20030057156A1 (en) 2001-03-08 2003-03-27 Dean Peterson Atrial filter implants
US6503272B2 (en) 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US7374571B2 (en) 2001-03-23 2008-05-20 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of manufacture
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US6911036B2 (en) 2001-04-03 2005-06-28 Medtronic Vascular, Inc. Guidewire apparatus for temporary distal embolic protection
WO2002083224A2 (en) 2001-04-17 2002-10-24 Salviac Limited A catheter
ATE373449T1 (en) 2001-04-27 2007-10-15 Bard Inc C R HANDLE DESIGN FOR A MEDICAL CATHETER
US6676692B2 (en) 2001-04-27 2004-01-13 Intek Technology L.L.C. Apparatus for delivering, repositioning and/or retrieving self-expanding stents
US6746469B2 (en) 2001-04-30 2004-06-08 Advanced Cardiovascular Systems, Inc. Balloon actuated apparatus having multiple embolic filters, and method of use
DE10121210B4 (en) 2001-04-30 2005-11-17 Universitätsklinikum Freiburg Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production
US20050021123A1 (en) 2001-04-30 2005-01-27 Jurgen Dorn Variable speed self-expanding stent delivery system and luer locking connector
US7374560B2 (en) 2001-05-01 2008-05-20 St. Jude Medical, Cardiology Division, Inc. Emboli protection devices and related methods of use
US6716238B2 (en) 2001-05-10 2004-04-06 Scimed Life Systems, Inc. Stent with detachable tethers and method of using same
US6682558B2 (en) 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6663663B2 (en) 2001-05-14 2003-12-16 M.I. Tech Co., Ltd. Stent
US6936067B2 (en) 2001-05-17 2005-08-30 St. Jude Medical Inc. Prosthetic heart valve with slit stent
US6821291B2 (en) 2001-06-01 2004-11-23 Ams Research Corporation Retrievable stent and method of use thereof
KR100393548B1 (en) 2001-06-05 2003-08-02 주식회사 엠아이텍 Stent
DE60115104T2 (en) 2001-06-08 2006-08-03 Rex Medical, L.P. VASCULAR FLAP DEVICE FOR APPROACHING THE VESSEL WALL
US6818013B2 (en) 2001-06-14 2004-11-16 Cordis Corporation Intravascular stent device
GB0114918D0 (en) 2001-06-19 2001-08-08 Vortex Innovation Ltd Devices for repairing aneurysms
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
US7377938B2 (en) 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US6755854B2 (en) 2001-07-31 2004-06-29 Advanced Cardiovascular Systems, Inc. Control device and mechanism for deploying a self-expanding medical device
FR2828263B1 (en) 2001-08-03 2007-05-11 Philipp Bonhoeffer DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE
US6896002B2 (en) 2001-08-21 2005-05-24 Scimed Life Systems, Inc Pressure transducer protection valve
WO2003018100A1 (en) 2001-08-22 2003-03-06 Hasan Semih Oktay Flexible mems actuated controlled expansion stent
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
US20030229390A1 (en) 2001-09-17 2003-12-11 Control Delivery Systems, Inc. On-stent delivery of pyrimidines and purine analogs
US6616682B2 (en) 2001-09-19 2003-09-09 Jomed Gmbh Methods and apparatus for distal protection during a medical procedure
US20030065386A1 (en) 2001-09-28 2003-04-03 Weadock Kevin Shaun Radially expandable endoprosthesis device with two-stage deployment
US7172572B2 (en) 2001-10-04 2007-02-06 Boston Scientific Scimed, Inc. Manifold system for a medical device
US6976974B2 (en) 2002-10-23 2005-12-20 Scimed Life Systems, Inc. Rotary manifold syringe
US6790237B2 (en) 2001-10-09 2004-09-14 Scimed Life Systems, Inc. Medical stent with a valve and related methods of manufacturing
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US6866669B2 (en) 2001-10-12 2005-03-15 Cordis Corporation Locking handle deployment mechanism for medical device and method
US6939352B2 (en) 2001-10-12 2005-09-06 Cordis Corporation Handle deployment mechanism for medical device and method
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
GB0125925D0 (en) 2001-10-29 2001-12-19 Univ Glasgow Mitral valve prosthesis
US6712843B2 (en) 2001-11-20 2004-03-30 Scimed Life Systems, Inc Stent with differential lengthening/shortening members
US6890340B2 (en) 2001-11-29 2005-05-10 Medtronic Vascular, Inc. Apparatus for temporary intraluminal protection
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
EP1461112B1 (en) 2001-12-05 2012-11-21 Sagax Inc. Endovascular device for entrapment of particulate matter and method for use
US7041139B2 (en) 2001-12-11 2006-05-09 Boston Scientific Scimed, Inc. Ureteral stents and related methods
US6676668B2 (en) 2001-12-12 2004-01-13 C.R. Baed Articulating stone basket
US7189258B2 (en) 2002-01-02 2007-03-13 Medtronic, Inc. Heart valve system
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US20030130729A1 (en) 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US6723116B2 (en) 2002-01-14 2004-04-20 Syde A. Taheri Exclusion of ascending/descending aorta and/or aortic arch aneurysm
US20030135162A1 (en) 2002-01-17 2003-07-17 Scimed Life Systems, Inc. Delivery and retrieval manifold for a distal protection filter
US6730377B2 (en) 2002-01-23 2004-05-04 Scimed Life Systems, Inc. Balloons made from liquid crystal polymer blends
US6689144B2 (en) 2002-02-08 2004-02-10 Scimed Life Systems, Inc. Rapid exchange catheter and methods for delivery of vaso-occlusive devices
US7708771B2 (en) * 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
WO2003073962A1 (en) 2002-03-05 2003-09-12 Salviac Limited An embolic protection system
US20030176884A1 (en) 2002-03-12 2003-09-18 Marwane Berrada Everted filter device
US7163556B2 (en) 2002-03-21 2007-01-16 Providence Health System - Oregon Bioprosthesis and method for suturelessly making same
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7052511B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Delivery system and method for deployment of foreshortening endoluminal devices
US20030195609A1 (en) 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US20030199759A1 (en) 2002-04-18 2003-10-23 Richard Merwin F. Coronary catheter with radiopaque length markers
US8721713B2 (en) 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US20030199971A1 (en) 2002-04-23 2003-10-23 Numed, Inc. Biological replacement valve assembly
WO2003092554A1 (en) 2002-05-03 2003-11-13 The General Hospital Corporation Involuted endovascular valve and method of construction
US8070769B2 (en) 2002-05-06 2011-12-06 Boston Scientific Scimed, Inc. Inverted embolic protection filter
US6830575B2 (en) 2002-05-08 2004-12-14 Scimed Life Systems, Inc. Method and device for providing full protection to a stent
US7141064B2 (en) 2002-05-08 2006-11-28 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
EP1507492A1 (en) 2002-05-10 2005-02-23 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
US20030225445A1 (en) 2002-05-14 2003-12-04 Derus Patricia M. Surgical stent delivery devices and methods
US7585309B2 (en) 2002-05-16 2009-09-08 Boston Scientific Scimed, Inc. Aortic filter
US20040117004A1 (en) 2002-05-16 2004-06-17 Osborne Thomas A. Stent and method of forming a stent with integral barbs
EP1870018A3 (en) 2002-05-30 2008-08-06 The Board of Trustees of The Leland Stanford Junior University Apparatus and methods for coronary sinus access
US7717934B2 (en) 2002-06-14 2010-05-18 Ev3 Inc. Rapid exchange catheters usable with embolic protection devices
US7329268B2 (en) 2002-07-02 2008-02-12 Warsaw Orthopedic, Inc. Expandable percutaneous sheath
US7166120B2 (en) 2002-07-12 2007-01-23 Ev3 Inc. Catheter with occluding cuff
US7232452B2 (en) 2002-07-12 2007-06-19 Ev3 Inc. Device to create proximal stasis
US7141063B2 (en) 2002-08-06 2006-11-28 Icon Medical Corp. Stent with micro-latching hinge joints
EP1388328A1 (en) 2002-08-07 2004-02-11 Abbott Laboratories Vascular Enterprises Limited Apparatus for delivering and deployment of an expandable stent within a blood vessel
US6969395B2 (en) 2002-08-07 2005-11-29 Boston Scientific Scimed, Inc. Electroactive polymer actuated medical devices
DE20321838U1 (en) 2002-08-13 2011-02-10 JenaValve Technology Inc., Wilmington Device for anchoring and aligning heart valve prostheses
US6863668B2 (en) 2002-08-16 2005-03-08 Edwards Lifesciences Corporation Articulation mechanism for medical devices
US7041132B2 (en) 2002-08-16 2006-05-09 3F Therapeutics, Inc, Percutaneously delivered heart valve and delivery means thereof
WO2004019817A1 (en) 2002-08-27 2004-03-11 Amir Belson Embolic protection device
US20040092858A1 (en) 2002-08-28 2004-05-13 Heart Leaflet Technologies, Inc. Leaflet valve
ES2349952T3 (en) 2002-08-29 2011-01-13 St. Jude Medical, Cardiology Division, Inc. IMPLANTABLE DEVICES FOR CONTROLLING THE INTERNAL CIRCUMFERENCE OF AN ANATOMICAL ORIFICE OR LUMEN.
KR100442330B1 (en) 2002-09-03 2004-07-30 주식회사 엠아이텍 Stent and manufacturing method the same
AU2003268379A1 (en) 2002-09-03 2004-03-29 John R. Fagan Arterial embolic filter deployed from catheter
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
CO5500017A1 (en) 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
US20040059409A1 (en) 2002-09-24 2004-03-25 Stenzel Eric B. Method of applying coatings to a medical device
US7998163B2 (en) 2002-10-03 2011-08-16 Boston Scientific Scimed, Inc. Expandable retrieval device
WO2004037128A1 (en) 2002-10-24 2004-05-06 Boston Scientific Limited Venous valve apparatus and method
US7481823B2 (en) 2002-10-25 2009-01-27 Boston Scientific Scimed, Inc. Multiple membrane embolic protection filter
US7766820B2 (en) 2002-10-25 2010-08-03 Nmt Medical, Inc. Expandable sheath tubing
US6814746B2 (en) 2002-11-01 2004-11-09 Ev3 Peripheral, Inc. Implant delivery system with marker interlock
WO2004041126A1 (en) 2002-11-08 2004-05-21 Jacques Seguin Endoprosthesis for vascular bifurcation
WO2004043273A2 (en) 2002-11-13 2004-05-27 Rosengart Todd K Apparatus and method for cutting a heart valve
WO2004043293A2 (en) 2002-11-13 2004-05-27 Viacor, Inc. Cardiac valve procedure methods and devices
US7527636B2 (en) 2002-11-14 2009-05-05 Medtronic Vascular, Inc Intraluminal guidewire with hydraulically collapsible self-expanding protection device
US20040098022A1 (en) 2002-11-14 2004-05-20 Barone David D. Intraluminal catheter with hydraulically collapsible self-expanding protection device
US7141061B2 (en) 2002-11-14 2006-11-28 Synecor, Llc Photocurable endoprosthesis system
US7001425B2 (en) 2002-11-15 2006-02-21 Scimed Life Systems, Inc. Braided stent method for its manufacture
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
FR2847155B1 (en) 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
AU2003283792A1 (en) 2002-11-29 2004-06-23 Mindguard Ltd. Braided intraluminal device for stroke prevention
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US6984242B2 (en) 2002-12-20 2006-01-10 Gore Enterprise Holdings, Inc. Implantable medical device assembly
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US20040138694A1 (en) 2003-01-15 2004-07-15 Scimed Life Systems, Inc. Intravascular filtering membrane and method of making an embolic protection filter device
US7753945B2 (en) 2003-01-17 2010-07-13 Gore Enterprise Holdings, Inc. Deployment system for an endoluminal device
US7762044B2 (en) 2003-01-27 2010-07-27 Medtronic Vascular, Inc. Packaging for stent delivery systems
GB2398245B (en) 2003-02-06 2007-03-28 Great Ormond Street Hospital F Valve prosthesis
US7740644B2 (en) 2003-02-24 2010-06-22 Boston Scientific Scimed, Inc. Embolic protection filtering device that can be adapted to be advanced over a guidewire
WO2004078065A2 (en) 2003-03-03 2004-09-16 Sinus Rhythm Technologies, Inc. Electrical conduction block implant device
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
GB2407146B (en) 2003-03-20 2006-04-26 Aortech Internat Plc Valve leaflet for use in cardiac valve prosthesis
US20060271081A1 (en) 2003-03-30 2006-11-30 Fidel Realyvasquez Apparatus and methods for valve repair
US7871434B2 (en) 2003-04-01 2011-01-18 Cook Incorporated Percutaneously deployed vascular valves
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7175656B2 (en) 2003-04-18 2007-02-13 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement
US7591832B2 (en) 2003-04-24 2009-09-22 Medtronic, Inc. Expandable guide sheath and apparatus with distal protection and methods for use
DE602004023350D1 (en) 2003-04-30 2009-11-12 Medtronic Vascular Inc Percutaneous inserted provisional valve
US6969396B2 (en) 2003-05-07 2005-11-29 Scimed Life Systems, Inc. Filter membrane with increased surface area
US7235093B2 (en) 2003-05-20 2007-06-26 Boston Scientific Scimed, Inc. Mechanism to improve stent securement
US20040243221A1 (en) 2003-05-27 2004-12-02 Fawzi Natalie V. Endovascular graft including substructure for positioning and sealing within vasculature
US7625364B2 (en) 2003-05-27 2009-12-01 Cardia, Inc. Flexible center connection for occlusion device
ATE481057T1 (en) 2003-05-28 2010-10-15 Cook Inc VALVE PROSTHESIS WITH VESSEL FIXING DEVICE
AU2003237985A1 (en) 2003-06-09 2005-01-28 3F Therapeutics, Inc. Atrioventricular heart valve and minimally invasive delivery systems thereof
KR20060112705A (en) 2003-07-08 2006-11-01 벤터 테크놀로지 리미티드 Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
US7744620B2 (en) 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
ATE442107T1 (en) 2003-07-21 2009-09-15 Univ Pennsylvania PERCUTANE HEART VALVE
DE10334868B4 (en) 2003-07-29 2013-10-17 Pfm Medical Ag Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it
US7153324B2 (en) 2003-07-31 2006-12-26 Cook Incorporated Prosthetic valve devices and methods of making such devices
WO2005011535A2 (en) 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
DE10340265A1 (en) 2003-08-29 2005-04-07 Sievers, Hans-Hinrich, Prof. Dr.med. Prosthesis for the replacement of the aortic and / or mitral valve of the heart
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
WO2005023358A1 (en) 2003-09-03 2005-03-17 Acumen Medical, Inc. Expandable sheath for delivering instruments and agents into a body lumen
US7993384B2 (en) 2003-09-12 2011-08-09 Abbott Cardiovascular Systems Inc. Delivery system for medical devices
US8535344B2 (en) 2003-09-12 2013-09-17 Rubicon Medical, Inc. Methods, systems, and devices for providing embolic protection and removing embolic material
US7758625B2 (en) 2003-09-12 2010-07-20 Abbott Vascular Solutions Inc. Delivery system for medical devices
EG24012A (en) 2003-09-24 2008-03-23 Wael Mohamed Nabil Lotfy Valved balloon stent
US9579194B2 (en) * 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US10219899B2 (en) 2004-04-23 2019-03-05 Medtronic 3F Therapeutics, Inc. Cardiac valve replacement systems
US20050075728A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
EP1684671B1 (en) 2003-10-06 2020-09-30 Medtronic 3F Therapeutics, Inc. Minimally invasive valve replacement system
WO2005037338A1 (en) 2003-10-14 2005-04-28 Cook Incorporated Hydrophilic coated medical device
ATE464864T1 (en) 2003-10-15 2010-05-15 Cook Inc HOLDING DEVICE FOR A PROSTHESIS STORAGE SYSTEM
US7175654B2 (en) 2003-10-16 2007-02-13 Cordis Corporation Stent design having stent segments which uncouple upon deployment
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US7419498B2 (en) 2003-10-21 2008-09-02 Nmt Medical, Inc. Quick release knot attachment system
US7070616B2 (en) 2003-10-31 2006-07-04 Cordis Corporation Implantable valvular prosthesis
US7347869B2 (en) 2003-10-31 2008-03-25 Cordis Corporation Implantable valvular prosthesis
WO2005048883A1 (en) 2003-11-13 2005-06-02 Fidel Realyvasquez Methods and apparatus for valve repair
US6972025B2 (en) 2003-11-18 2005-12-06 Scimed Life Systems, Inc. Intravascular filter with bioabsorbable centering element
US9241735B2 (en) 2003-12-05 2016-01-26 Onset Medical Corporation Expandable percutaneous sheath
US7186265B2 (en) 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
US20050137683A1 (en) 2003-12-19 2005-06-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137696A1 (en) 2003-12-23 2005-06-23 Sadra Medical Apparatus and methods for protecting against embolization during endovascular heart valve replacement
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US7748389B2 (en) 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7824442B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
EP2529699B1 (en) 2003-12-23 2014-01-29 Sadra Medical, Inc. Repositionable heart valve
US7824443B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137691A1 (en) 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
WO2005069850A2 (en) 2004-01-15 2005-08-04 Macoviak John A Trestle heart valve replacement
US7468070B2 (en) 2004-01-23 2008-12-23 Boston Scientific Scimed, Inc. Stent delivery catheter
US7597711B2 (en) 2004-01-26 2009-10-06 Arbor Surgical Technologies, Inc. Heart valve assembly with slidable coupling connections
US7470285B2 (en) 2004-02-05 2008-12-30 Children's Medical Center Corp. Transcatheter delivery of a replacement heart valve
US7311730B2 (en) 2004-02-13 2007-12-25 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
CA2813136A1 (en) 2004-02-27 2005-09-15 Aortx, Inc. Prosthetic heart valve delivery systems and methods
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
WO2005086888A2 (en) 2004-03-09 2005-09-22 Fidel Realyvasquez Off pump aortic valve replacement for valve prosthesis
EP2308425B2 (en) 2004-03-11 2023-10-18 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous Heart Valve Prosthesis
CA2561188A1 (en) 2004-03-31 2005-10-20 Med Institute, Inc. Endoluminal graft with a prosthetic valve
US7637937B2 (en) 2004-04-08 2009-12-29 Cook Incorporated Implantable medical device with optimized shape
ATE367132T1 (en) 2004-05-25 2007-08-15 Cook William Europ STENT AND STENT REMOVING DEVICE
US7122020B2 (en) 2004-06-25 2006-10-17 Mogul Enterprises, Inc. Linkage steering mechanism for deflectable catheters
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
US7276078B2 (en) 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
US8500785B2 (en) 2004-07-13 2013-08-06 Boston Scientific Scimed, Inc. Catheter
FR2874813B1 (en) 2004-09-07 2007-06-22 Perouse Soc Par Actions Simpli VALVULAR PROSTHESIS
EP1819391B1 (en) 2004-09-09 2020-02-19 Onset Medical Corporation Expandable transluminal sheath
US6951571B1 (en) 2004-09-30 2005-10-04 Rohit Srivastava Valve implanting device
WO2006055982A2 (en) 2004-11-22 2006-05-26 Avvrx Ring-shaped valve prosthesis attachment device
US7989157B2 (en) 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
US7918880B2 (en) 2005-02-16 2011-04-05 Boston Scientific Scimed, Inc. Self-expanding stent and delivery system
US20060195183A1 (en) 2005-02-18 2006-08-31 The Cleveland Clinic Foundation Apparatus and methods for replacing a cardiac valve
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
CN101180010B (en) 2005-05-24 2010-12-01 爱德华兹生命科学公司 Rapid deployment prosthetic heart valve
EP1915105B1 (en) 2005-05-27 2016-08-03 HLT, Inc. Stentless support structure
US8092481B2 (en) 2005-06-03 2012-01-10 Onset Medical Corporation Expandable percutaneous sheath
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US20060287668A1 (en) 2005-06-16 2006-12-21 Fawzi Natalie V Apparatus and methods for intravascular embolic protection
WO2007005799A1 (en) 2005-06-30 2007-01-11 Abbott Laboratories Delivery system for a medical device
US8968379B2 (en) 2005-09-02 2015-03-03 Medtronic Vascular, Inc. Stent delivery system with multiple evenly spaced pullwires
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
US20080188928A1 (en) 2005-09-16 2008-08-07 Amr Salahieh Medical device delivery sheath
US20070173918A1 (en) 2005-09-30 2007-07-26 Dreher James H Apparatus and methods for locating an ostium of a vessel
DE102005052628B4 (en) 2005-11-04 2014-06-05 Jenavalve Technology Inc. Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter
EP1988851A2 (en) 2006-02-14 2008-11-12 Sadra Medical, Inc. Systems and methods for delivering a medical implant
EP1991168B1 (en) 2006-02-16 2016-01-27 Transcatheter Technologies GmbH Minimally invasive heart valve replacement
EP2023860A2 (en) 2006-04-29 2009-02-18 Arbor Surgical Technologies, Inc. Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them
US8376865B2 (en) 2006-06-20 2013-02-19 Cardiacmd, Inc. Torque shaft and torque shaft drive
US20080033541A1 (en) 2006-08-02 2008-02-07 Daniel Gelbart Artificial mitral valve
CN101662999B (en) 2006-09-28 2016-01-20 心叶科技公司 For the means of delivery of percutaneous conveying prosthese
WO2008103283A2 (en) 2007-02-16 2008-08-28 Medtronic, Inc. Delivery systems and methods of implantation for replacement prosthetic heart valves
US7753949B2 (en) 2007-02-23 2010-07-13 The Trustees Of The University Of Pennsylvania Valve prosthesis systems and methods
US8070802B2 (en) 2007-02-23 2011-12-06 The Trustees Of The University Of Pennsylvania Mitral valve system
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
ES2475144T3 (en) 2007-06-26 2014-07-10 St. Jude Medical, Inc. Apparatus for implanting prosthetic heart valves folding / expandable
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8192351B2 (en) 2007-08-13 2012-06-05 Paracor Medical, Inc. Medical device delivery system having integrated introducer
EP2185107B1 (en) 2007-09-07 2017-01-25 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US20090171456A1 (en) 2007-12-28 2009-07-02 Kveen Graig L Percutaneous heart valve, system, and method
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US8052607B2 (en) 2008-04-22 2011-11-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Ultrasound imaging catheter with pivoting head
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
CN102170833B (en) 2008-08-08 2014-03-26 因赛普特有限责任公司 Apparatus and methods for accessing and removing material from body lumens
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US8690936B2 (en) 2008-10-10 2014-04-08 Edwards Lifesciences Corporation Expandable sheath for introducing an endovascular delivery device into a body
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US20100217382A1 (en) 2009-02-25 2010-08-26 Edwards Lifesciences Mitral valve replacement with atrial anchoring
EP4129238A1 (en) 2010-03-05 2023-02-08 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US9173736B2 (en) * 2011-04-28 2015-11-03 Medtronic Vascular, Inc. Method of making an endoluminal vascular prosthesis
EP2731550B1 (en) 2011-07-12 2016-02-24 Boston Scientific Scimed, Inc. Coupling system for a replacement valve
US9119716B2 (en) 2011-07-27 2015-09-01 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
CA2847687C (en) 2011-09-09 2017-10-17 Endoluminal Sciences Pty Ltd. Means for controlled sealing of endovascular devices
JP6184963B2 (en) 2011-10-05 2017-08-23 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Thin seal material for replacement heart valve and method of forming the same
US8778020B2 (en) 2011-11-08 2014-07-15 Boston Scientific Scimed, Inc. Replacement heart valve leaflet stitching method and device
EP2779945B1 (en) 2011-11-15 2021-07-14 Boston Scientific Scimed, Inc. Medical device with keyed locking structures
WO2013096644A1 (en) 2011-12-20 2013-06-27 Boston Scientific Scimed, Inc. Apparatus for endovascularly replacing a heart valve
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
EP2846736B1 (en) 2012-05-09 2018-02-28 Boston Scientific Scimed, Inc. Reduced profile valve with locking elements
WO2014011888A1 (en) 2012-07-12 2014-01-16 Boston Scientific Scimed, Inc. Low profile heart valve delivery system and method
US9398951B2 (en) * 2013-03-12 2016-07-26 St. Jude Medical, Cardiology Division, Inc. Self-actuating sealing portions for paravalvular leak protection
US20140350668A1 (en) 2013-03-13 2014-11-27 Symetis Sa Prosthesis Seals and Methods for Sealing an Expandable Prosthesis
CA2900367C (en) * 2013-03-15 2020-12-22 Edwards Lifesciences Corporation Valved aortic conduits
EP4183373A1 (en) * 2013-03-15 2023-05-24 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
CN103705315B (en) * 2013-12-12 2015-10-21 宁波健世生物科技有限公司 Prevent the aortic valve stent of perivalvular leakage
WO2015175450A1 (en) * 2014-05-16 2015-11-19 St. Jude Medical, Cardiology Division, Inc. Transcatheter valve with paravalvular leak sealing ring

Also Published As

Publication number Publication date
US20160262878A1 (en) 2016-09-15
US20190021853A1 (en) 2019-01-24
US10080652B2 (en) 2018-09-25
CN107592804B (en) 2021-05-25
EP3267945A1 (en) 2018-01-17
CN107592804A (en) 2018-01-16
US11065113B2 (en) 2021-07-20
WO2016148942A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
US20210307902A1 (en) Prosthetic Heart Valve Having an Improved Tubular Seal
US10201417B2 (en) Prosthetic heart valve having tubular seal
US9788942B2 (en) Prosthetic heart valve having tubular seal
US9839512B2 (en) Prosthetic heart valve having notched leaflet
US9861477B2 (en) Prosthetic heart valve square leaflet-leaflet stitch
US11744700B2 (en) Prosthetic heart valve having multi-level sealing member
US11273031B2 (en) Prosthetic heart valve with reduced stitching
CA3072814C (en) Prosthetic valve with expandable frame and associated systems and methods
US6494909B2 (en) Endovascular valve
JP2022181217A (en) Skirt assembly for implantable prosthetic valve
JP2021514745A (en) Artificial mitral valve with improved anchors and seals
JP7521829B2 (en) Heart valve prosthesis, artificial valve therefrom and manufacturing method
CN217409070U (en) Implantable medical device
JP2024530811A (en) Textiles, methods for making same, and medical devices using same - Patents.com

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION